Canopy Growth (CGC) 10-Q 6 Aug 21 2022 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Jun. 30, 2021	Aug. 05, 2021
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2021
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Entity Registrant Name	Canopy Growth Corporation
Entity Central Index Key	0001737927
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Current Fiscal Year End Date	--03-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		393,179,437
Entity Shell Company	false
Entity Small Business	false
Entity Emerging Growth Company	false
Title of 12(b) Security	Common shares, no par value
Trading Symbol	CGC
Security Exchange Name	NASDAQ
Entity File Number	001-38496
Entity Incorporation, State or Country Code	Z4
Entity Tax Identification Number	00-0000000
Entity Address, Address Line One	1 Hershey Drive
Entity Address, City or Town	Smiths Falls
Entity Address, State or Province	ON
Entity Address, Postal Zip Code	K7A 0A8
City Area Code	855
Local Phone Number	558-9333
Document Quarterly Report	true
Document Transition Report	false

Condensed Interim Consolidated

Condensed Interim Consolidated Balance Sheets (Unaudited) - CAD ($) $ in Thousands	Jun. 30, 2021	Mar. 31, 2021
Current assets:
Cash and cash equivalents	$ 559,840	$ 1,154,653
Short-term investments	1,491,286	1,144,563
Restricted short-term investments	14,336	11,332
Amounts receivable, net	106,455	92,435
Inventory	411,675	367,979
Prepaid expenses and other assets	91,584	67,232
Total current assets	2,675,176	2,838,194
Other financial assets	791,658	708,167
Property, plant and equipment	1,142,614	1,074,537
Intangible assets	347,063	308,167
Goodwill	2,000,458	1,889,354
Other assets	9,514	5,061
Total assets	6,966,483	6,823,480
Current liabilities:
Accounts payable	91,339	67,262
Other accrued expenses and liabilities	79,938	100,813
Current portion of long-term debt	15,705	9,827
Other liabilities	69,148	106,428
Total current liabilities	256,130	284,330
Long-term debt	1,545,073	1,573,136
Deferred income tax liabilities	26,570	21,379
Other liabilities	109,038	107,240
Total liabilities	2,686,129	3,201,660
Commitments and contingencies
Redeemable noncontrolling interest	135,300	135,300
Canopy Growth Corporation shareholders' equity:
Common shares - $nil par value; Authorized - unlimited number of shares; Issued - 393,119,100 shares and 382,875,179 shares, respectively	7,463,557	7,168,557
Additional paid-in capital	2,413,779	2,415,650
Accumulated other comprehensive loss	(61,518)	(34,240)
Deficit	(5,675,738)	(6,068,156)
Total Canopy Growth Corporation shareholders' equity	4,140,080	3,481,811
Noncontrolling interests	4,974	4,709
Total shareholders' equity	4,145,054	3,486,520
Total liabilities and shareholders' equity	6,966,483	6,823,480
Acreage
Current liabilities:
Liability arising from Acreage Arrangement	450,000	600,000
Warrant
Current liabilities:
Derivative liability	$ 299,318	$ 615,575

Condensed Interim Consolidate_2

Condensed Interim Consolidated Balance Sheets (Parenthetical) (Unaudited) - shares	Jun. 30, 2021	Mar. 31, 2021
Statement Of Financial Position [Abstract]
Common stock, shares issued	393,119,100	382,875,179

Condensed Interim Consolidate_3

Condensed Interim Consolidated Statements of Operations and Comprehensive (Loss) Income (Unaudited) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Income Statement [Abstract]
Revenue	$ 155,423	$ 119,088
Excise taxes	19,214	8,672
Net revenue	136,209	110,416
Cost of goods sold	108,971	103,921
Gross margin	27,238	6,495
Operating expenses
Selling, general and administrative expenses	112,574	135,392
Share-based compensation	13,126	30,685
Asset impairment and restructuring costs	89,249	12,794
Total operating expenses	214,949	178,871
Operating loss	(187,711)	(172,376)
Loss from equity method investments	(100)	(7,189)
Other income (expense), net	580,666	48,205
Income (loss) before income taxes	392,855	(131,360)
Income tax (expense) recovery	(2,900)	3,038
Net income (loss)	389,955	(128,322)
Net loss attributable to noncontrolling interests and redeemable noncontrolling interest	(2,463)	(19,821)
Net income (loss) attributable to Canopy Growth Corporation	$ 392,418	$ (108,501)
Basic earnings (loss) per share	$ 1.02	$ (0.30)
Basic weighted average common shares outstanding	384,055,133	363,763,347
Diluted earnings (loss) per share	$ 0.84	$ (0.30)
Diluted weighted average common shares outstanding	404,546,243	363,763,347
Comprehensive loss:
Net income (loss)	$ 389,955	$ (128,322)
Other comprehensive income (loss), net of income tax effect
Fair value changes of own credit risk of financial liabilities	660	(15,360)
Foreign currency translation	(27,938)	(53,124)
Total other comprehensive income (loss), net of income tax effect	(27,278)	(68,484)
Comprehensive income (loss)	362,677	(196,806)
Comprehensive income (loss) attributable to noncontrolling interests and redeemable noncontrolling interest	(2,463)	(19,821)
Comprehensive income (loss) attributable to Canopy Growth Corporation	$ 365,140	$ (176,985)

Condensed Interim Consolidate_4

Condensed Interim Consolidated Statements of Shareholder's Equity (Unaudited) - CAD ($) $ in Thousands	Total	Common Shares	Additional Paid-in capitalShare-based Reserve	Additional Paid-in capitalWarrant	Additional Paid-in capitalOwnership Changes	Additional Paid-in capitalRedeemable Noncontrolling Interest	Accumulated Other Comprehensive Income (Loss)	Deficit	Noncontrolling Interests
Beginning balance at Mar. 31, 2020	$ 5,108,120	$ 6,373,544	$ 517,741	$ 2,638,951	$ (501,403)	$ (40,134)	$ 220,899	$ (4,323,236)	$ 221,758
Other issuances of common shares and warrants	(584)	26,214	(26,798)
Exercise of warrants	244,990	315,256		(70,266)
Exercise of Omnibus Plan stock options	4,722	9,231	(4,509)
Share-based compensation	29,140		29,140
Changes in redeemable noncontrolling interest	(11,850)					(22,513)			10,663
Ownership changes relating to noncontrolling interests	2,809				162				2,647
Comprehensive (loss) income	(196,806)						(68,484)	(108,501)	(19,821)
Ending balance at Jun. 30, 2020	5,180,541	6,724,245	515,574	2,568,685	(501,241)	(62,647)	152,415	(4,431,737)	215,247
Beginning balance at Mar. 31, 2021	3,486,520	7,168,557	480,786	2,568,438	(512,340)	(121,234)	(34,240)	(6,068,156)	4,709
Other issuances of common shares and warrants	260,223	285,915	(25,692)
Replacement equity instruments from the acquisition of Supreme Cannabis	18,916		5,566	13,350
Exercise of Omnibus Plan stock options	3,592	5,522	(1,930)
Share-based compensation	12,861		12,861
Issuance and vesting of restricted share units		3,563	(3,563)
Changes in redeemable noncontrolling interest						(2,463)			2,463
Ownership changes relating to noncontrolling interests	265								265
Comprehensive (loss) income	362,677						(27,278)	392,418	(2,463)
Ending balance at Jun. 30, 2021	$ 4,145,054	$ 7,463,557	$ 468,028	$ 2,581,788	$ (512,340)	$ (123,697)	$ (61,518)	$ (5,675,738)	$ 4,974

Condensed Interim Consolidate_5

Condensed Interim Consolidated Statements of Cash Flows (Unaudited) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Cash flows from operating activities:
Net income (loss)	$ 389,955	$ (128,322)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of property, plant and equipment	17,116	17,415
Amortization of intangible assets	8,016	16,632
Share of loss on equity method investments	100	7,189
Share-based compensation	13,126	30,685
Asset impairment and restructuring costs	89,249	12,794
Income tax expense (recovery)	2,900	(3,038)
Non-cash foreign currency	(17,846)	8,688
Interest paid	(23,666)	(57)
Change in operating assets and liabilities, net of effects from purchases of businesses:
Amounts receivable	(4,946)	17,577
Prepaid expenses and other assets	(8,804)	(16,059)
Inventory	44,228	(10,772)
Accounts payable and accrued liabilities	(16,960)	3,755
Other, including non-cash fair value adjustments	(658,248)	(75,033)
Net cash used in operating activities	(165,780)	(118,546)
Cash flows from investing activities:
Purchases of and deposits on property, plant and equipment	(20,279)	(61,547)
Purchases of intangible assets	(833)	(3,088)
Proceeds on sale of intangible assets		18,337
Purchases of short-term investments	(346,603)	(382,486)
Net cash proceeds on sale of subsidiaries	10,324
Sale of (investments in) other financial assets	56	(2,564)
Recovery of amounts related to construction financing		10,000
Payment of acquisition related liabilities	(8,367)	(4,511)
Net cash outflow on acquisition of noncontrolling interests		(125)
Net cash outflow on acquisition of subsidiaries	(8,857)
Net cash used in investing activities	(374,559)	(425,984)
Cash flows from financing activities:
Payment of share issue costs	(444)	(595)
Proceeds from issuance of shares by RIV Capital		92
Proceeds from exercise of stock options	3,592	4,722
Proceeds from exercise of warrants		244,990
Issuance of long-term debt		4,439
Repayment of long-term debt	(48,116)	(6,345)
Net cash (used in) provided by financing activities	(44,968)	247,303
Effect of exchange rate changes on cash and cash equivalents	(9,506)	(30,079)
Net decrease in cash and cash equivalents	(594,813)	(327,306)
Cash and cash equivalents, beginning of period	1,154,653	1,303,176
Cash and cash equivalents, end of period	559,840	975,870
Cash received during the period:
Income taxes	33	2,000
Cash paid during the period:
Income taxes	330	408
Noncash investing and financing activities
Additions to property, plant and equipment	$ 4,776	$ 17,337

Description of Business

Description of Business	3 Months Ended
	Jun. 30, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Description of Business	1 Canopy Growth Corporation is a publicly traded corporation, incorporated in Canada, with its head office located at 1 Hershey Drive, Smiths Falls, Ontario. References herein to “Canopy Growth” or “the Company” refer to Canopy Growth Corporation and its subsidiaries. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult recreational and medical purposes under a portfolio of distinct brands in Canada pursuant to the Cannabis Act

Basis of Presentation

Basis of Presentation	3 Months Ended
	Jun. 30, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Basis of Presentation	2 These condensed interim consolidated financial statements have been presented in Canadian dollars and are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Canopy Growth has determined that the Canadian dollar is the most relevant and appropriate reporting currency as, despite continuing shifts in the relative size of our operations across multiple geographies, the majority of our operations are conducted in Canadian dollars and our financial results are prepared and reviewed internally by management in Canadian dollars. Our condensed interim consolidated financial statements, and the financial information contained herein, are reported in thousands of Canadian dollars, except share and per share amounts or as otherwise stated. Certain information and footnote disclosures normally included in the audited annual consolidated financial statements prepared in accordance with U.S. GAAP have been omitted or condensed. These condensed interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended March 31, 2021 (the “Annual Report”) and have been prepared on a basis consistent with the accounting policies as described in the Annual Report. These condensed interim consolidated financial statements are unaudited and reflect adjustments (consisting of normal recurring adjustments) that are, in the opinion of management, necessary to provide a fair statement of results for the interim periods in accordance with U.S. GAAP. The results reported in these condensed interim consolidated financial statements should not be regarded as necessarily indicative of results that may be expected for an entire fiscal year. The policies set out below are consistently applied to all periods presented, unless otherwise noted. Principles of consolidation The accompanying condensed interim consolidated financial statements include the accounts of the Company and all entities in which the Company either has a controlling voting interest or is the primary beneficiary of a variable interest entity. All intercompany accounts and transactions have been eliminated on consolidation. Information on the Company’s subsidiaries with noncontrolling interests is included in Note 20. Use of estimates The preparation of these condensed interim consolidated financial statements and accompanying notes in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ from those estimates. New accounting policies Recently Adopted Accounting Pronouncements Income Taxes In December 2019, the Financial Accounting Standards Board (“FASB”) issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes period, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The Company adopted ASU 2019-12 as of April 1, 202 1 . There was no impact of adopting ASU 2019-12 on the condensed interim consolidated financial statements. Investments-Equity Securities In January 2020, the FASB issued ASU 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) Accounting Guidance not yet adopted Convertible Instruments and Contracts in an Entity’s Own Equity In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40):Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity simplifies the accounting for convertible instruments by reducing the number of accounting models for convertible debt instruments and convertible preferred stock. In addition, ASU 2020-06 enhances information transparency by making targeted improvements to the disclosures for convertible instruments and earnings-per-share (EPS) guidance and amends the guidance for the derivatives scope exception for contracts in an entity’s own equity to reduce form-over-substance-based accounting conclusions. ASU 2020-06 is effective for interim and annual periods beginning after December 15, 2021, with early adoption permitted after December 15, 2020.

Asset Impairment and Restructur

Asset Impairment and Restructuring Costs	3 Months Ended
	Jun. 30, 2021
Restructuring And Related Activities [Abstract]
Asset Impairment and Restructuring Costs	3. ASSET IMPAIRMENT AND RESTRUCTURING COSTS In the three months ended June 30, 2021, the Company recorded charges related to operational changes resulting from the continuing strategic review of its business as a result of recent acquisition activities, and the partial outcome of certain integration initiatives. Additionally, the Company recognized incremental costs associated with the closure of certain of its Canadian production facilities in December 2020. Charges totaling $89,249 were recognized in the three months ended June 30, 2021, primarily representing the difference between the net book value of the associated long-lived assets and their estimated fair value.

Cash and Cash Equivalents

Cash and Cash Equivalents	3 Months Ended
	Jun. 30, 2021
Cash And Cash Equivalents [Abstract]
Cash and Cash Equivalents	4. CASH AND CASH EQUIVALENTS The components of cash and cash equivalents are as follows: June 30, March 31, 2021 2021 Cash $ 367,284 $ 436,588 Cash equivalents 192,556 718,065 $ 559,840 $ 1,154,653

Short-term Investments

Short-term Investments	3 Months Ended
	Jun. 30, 2021
Short Term Investments [Abstract]
Short-term Investments	5. SHORT-TERM INVESTMENTS The components of short-term investments are as follows: June 30, March 31, 2021 2021 Term deposits $ 442,916 $ 463,824 Government securities 92,360 136,620 Asset-backed securities 252,848 16,342 Commercial paper and other 703,162 527,777 $ 1,491,286 $ 1,144,563 The amortized cost of short-term investments at June 30, 2021 is $1,492,227 (March 31, 2021 – $1,145,364).

Amounts Receivable, Net

Amounts Receivable, Net	3 Months Ended
	Jun. 30, 2021
Receivables [Abstract]
Amounts Receivable, Net	6. AMOUNTS RECEIVABLE, NET The components of amounts receivable, net are as follows: June 30, March 31, 2021 2021 Accounts receivable, net $ 87,582 $ 67,106 Indirect taxes receivable 8,674 8,281 Interest receivable 6,052 5,140 Other receivables 4,147 11,908 $ 106,455 $ 92,435 Included in the accounts receivable, net balance at June 30, 2021 is an allowance for doubtful accounts of $1,582 (March 31, 2021 – $1,411)

Inventory

Inventory	3 Months Ended
	Jun. 30, 2021
Inventory Disclosure [Abstract]
Inventory	7. INVENTORY The components of inventory are as follows: June 30, March 31, 2021 2021 Raw materials, packaging supplies and consumables $ 66,006 $ 55,554 Work in progress 219,816 223,652 Finished goods 125,853 88,773 $ 411,675 $ 367,979 In the three months ended June 30, 2021, the Company recorded write-downs related to inventory in cost of goods sold of $6,014 (three months ended June 30, 2020 – $19,386).

Prepaid Expenses and Other Asse

Prepaid Expenses and Other Assets	3 Months Ended
	Jun. 30, 2021
Prepaid Expense And Other Assets Current [Abstract]
Prepaid Expenses and Other Assets	8. PREPAID EXPENSES AND OTHER ASSETS The components of prepaid expenses and other assets are as follows: June 30, March 31, 2021 2021 Prepaid expenses $ 44,412 $ 28,349 Deposits 21,008 18,316 Prepaid inventory 1,157 1,496 Other assets 25,007 19,071 $ 91,584 $ 67,232

Other Financial Assets

Other Financial Assets	3 Months Ended
	Jun. 30, 2021
Schedule Of Investments [Abstract]
Other Financial Assets	9. OTHER FINANCIAL ASSETS The following table outlines changes in other financial assets. Additional details on how the fair value of significant investments is calculated are included in Note 21. Foreign Exercise of Balance at currency options / Balance at March 31, Fair value translation disposal June 30, Entity Instrument 2021 changes adjustments of shares 2021 TerrAscend Exchangeable Shares Exchangeable shares $ 385,000 $ 53,000 $ - $ - $ 438,000 TerrAscend Canada - October 2019 Term loan / debenture 10,240 540 - - 10,780 TerrAscend Canada - March 2020 Term loan / debenture 56,330 3,350 - - 59,680 Arise Bioscience Term loan / debenture 13,077 1,376 (171 ) - 14,282 TerrAscend - October 2019 Warrants 17,250 2,780 - - 20,030 TerrAscend - March 2020 Warrants 152,910 22,820 - - 175,730 TerrAscend - December 2020 Warrants 13,240 1,840 - - 15,080 TerrAscend Option 10,600 1,500 - - 12,100 Acreage Hempco 1 Debenture 27,448 1,302 (359 ) - 28,391 SLANG Warrants 9,400 (4,000 ) - - 5,400 Other - at fair value through net income (loss) Various 5,487 (356 ) - (100 ) 5,031 Other - classified as held for investment Loan receivable 7,185 - - (31 ) 7,154 $ 708,167 $ 84,152 $ (530 ) $ (131 ) $ 791,658 1

Property, Plant and Equipment

Property, Plant and Equipment	3 Months Ended
	Jun. 30, 2021
Property Plant And Equipment [Abstract]
Property, Plant and Equipment	10. PROPERTY, PLANT AND EQUIPMENT The components of property, plant and equipment are as follows: June 30, March 31, 2021 2021 Buildings and greenhouses $ 833,426 $ 651,166 Production and warehouse equipment 210,671 216,925 Leasehold improvements 101,163 106,837 Office and lab equipment 35,053 30,546 Land 33,158 34,747 Computer equipment 22,719 26,431 Right-of-use-assets Buildings and greenhouses 100,530 100,517 Production and warehouse equipment 530 530 Assets in process 26,653 129,428 1,363,903 1,297,127 Less: Accumulated depreciation (221,289 ) (222,590 ) $ 1,142,614 $ 1,074,537 Depreciation expense included in cost of goods sold for the three months ended June 30, 2021 is $10,462 (three months ended June 30, 2020 – $14,786). Depreciation expense included in selling, general and administrative expenses for the three months ended June 30, 2021 is $6,654 (three months ended June 30, 2020 – $2,629).

Intangible Assets

Intangible Assets	3 Months Ended
	Jun. 30, 2021
Intangible Assets Net Excluding Goodwill [Abstract]
Intangible Assets	11. INTANGIBLE ASSETS The components of intangible assets are as follows: June 30, 2021 March 31, 2021 Gross Net Gross Net Carrying Carrying Carrying Carrying Amount Amount Amount Amount Finite lived intangible assets Intellectual property $ 211,069 $ 165,077 $ 212,100 $ 168,655 Distribution channel 76,599 35,208 73,756 35,176 Software and domain names 29,655 18,193 27,836 18,149 Brands 21,102 7,241 21,812 8,894 Operating licenses 10,500 10,500 - - Amortizable intangibles in process 875 875 1,952 1,952 Total $ 349,800 $ 237,094 $ 337,456 $ 232,826 Indefinite lived intangible assets Acquired brands $ 101,969 $ 67,341 Operating licenses 8,000 8,000 Total intangible assets $ 347,063 $ 308,167 Amortization expense included in cost of goods sold for the three months ended June 30, 2021 is $18 ( three months ended June 30, 2020 (three months ended June 30, 2020 – $15,930

Goodwill

Goodwill	3 Months Ended
	Jun. 30, 2021
Goodwill And Intangible Assets Disclosure [Abstract]
Goodwill	12. GOODWILL The changes in the carrying amount of goodwill are as follows: Balance, March 31, 2020 $ 1,954,471 Foreign currency translation adjustments (65,117 ) Balance, March 31, 2021 $ 1,889,354 Purchase accounting allocations 122,374 Disposal of consolidated entities (5,245 ) Foreign currency translation adjustments (6,025 ) Balance, June 30, 2021 $ 2,000,458

Other Accrued Expenses and Liab

Other Accrued Expenses and Liabilities	3 Months Ended
	Jun. 30, 2021
Accounts Payable And Accrued Liabilities Current [Abstract]
Other Accrued Expenses and Liabilities	13. OTHER ACCRUED EXPENSES AND LIABILITIES The components of other accrued expenses and liabilities are as follows: June 30, March 31, 2021 2021 Employee compensation $ 36,061 $ 47,237 Taxes and government fees 14,250 13,550 Professional fees 7,303 11,544 Other 22,324 28,482 $ 79,938 $ 100,813

Debt

Debt	3 Months Ended
	Jun. 30, 2021
Debt Disclosure [Abstract]
Debt	14. DEBT The components of debt are as follows: June 30, March 31, Maturity Date 2021 2021 Convertible senior notes at 4.25% interest with semi-annual interest payments July 15, 2023 Principal amount $ 600,000 $ 600,000 Accrued interest 12,042 5,664 Non-credit risk fair value adjustment 52,620 109,710 Credit risk fair value adjustment (28,620 ) (27,960 ) 636,042 687,414 Convertible debentures September 10, 2025 30,532 - Accretion debentures September 10, 2025 9,802 - Credit facility March 18, 2026 880,927 891,677 Other revolving debt facility, loan, and financings 3,475 3,872 1,560,778 1,582,963 Less: current portion (15,705 ) (9,827 ) Long-term portion $ 1,545,073 $ 1,573,136 Credit Facility On March 18, 2021, the Company entered into a credit agreement (the “Credit Agreement”) providing for a five-year, first lien senior secured term loan facility in an aggregate principal amount of US$750,000 (the “Credit Facility”). The Company also has the ability to obtain up to an additional US$500,000 of incremental senior secured debt pursuant to the Credit Agreement. The Credit Facility has no principal payments, matures on March 18, 2026, has a coupon of LIBOR plus 8.50% and is subject to a LIBOR floor of 1.00%. In the event that LIBOR can no longer be adequately ascertained or is no longer available, an alternative rate as permitted under the Credit Agreement will be used. The Company’s obligations under the Credit Facility are guaranteed by material wholly-owned Canadian and U.S. subsidiaries of the Company. The Credit Facility is secured by substantially all of these assets, including material real property, of the borrowers and each of the guarantors. The Credit Agreement contains representations and warranties, and affirmative and negative covenants, including a financial covenant requiring minimum liquidity of US$200,000 at the end of each fiscal quarter. The proceeds from the Credit Facility were $ 893,160 , and the carrying amount is reflected net of financing costs. Convertible Notes On June 20, 2018, the Company issued convertible senior notes (the “Notes”) with an aggregate principal amount of $600,000. The Notes bear interest at a rate of 4.25% per annum, payable semi-annually on January 15th and July 15th of each year commencing from January 15, 2019. The Notes will mature on July 15, 2023. The Notes are subordinated in right of payment to any existing and future senior indebtedness, including indebtedness under the revolving credit facility. The Notes will rank senior in right of payment to any future subordinated borrowings. The Notes are effectively junior to any secured indebtedness and the Notes are structurally subordinated to all indebtedness and other liabilities of the Company’s subsidiaries. Holders of the Notes may convert the Notes at their option at any time from January 15, 2023 to the maturity date. The Notes will be convertible, at the holder’s option, at a conversion rate of 20.7577 common shares for every $1 principal amount of Notes (equal to an initial conversion price of approximately $48.18 per common share), subject to adjustments in certain events. In addition, the holder has the right to exercise the conversion option from September 30, 2018 to January 15, 2023, if (i) the market price of the Company common shares for at least 20 trading days during a period of 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day, (ii) during the 5 business day period after any consecutive 5 trading day period (the “measurement period”) in which the trading price per $1 principal amount of the Notes for each trading day in the measurement period was less than 98% of the product of the last reported sales price of the Company’s common shares and the conversion rate on each such trading day, (iii) the Notes are called for redemption or (iv) upon occurrence of certain corporate events (“Fundamental Change”). A Fundamental Change occurred upon completion of the investment by Constellation Brands, Inc. (“CBI”) in the Company in November 2018, and no holders of Notes surrendered any portion of their Notes in connection therewith. The Company may, upon conversion by the holder, elect to settle in either cash, common shares, or a combination of cash and common shares, subject to certain circumstances. Under the terms of the indenture, if a Fundamental Change occurs and a holder elects to convert its Notes from and including on the date of the Fundamental Change up to, and including, the business day immediately prior to the Fundamental Change repurchase date, the Company may be required to increase the conversion rate for the Notes so surrendered for conversion by a number of additional common shares. The Company cannot redeem the Notes prior to July 20, 2021, except in the event of certain changes in Canadian tax law. On or after July 20, 2021, the Company could redeem for cash, subject to certain conditions, any or all of the Notes, at its option, if the last reported sales price of the Company’s common shares for at least 20 trading days during any 30 consecutive trading day period ending within 5 trading days immediately preceding the date on which the Company provides notice of redemption exceeds 130% of the conversion price on each applicable trading day. The Company may also redeem the Notes, if certain tax laws related to Canadian withholding tax change subject to certain further conditions. The redemption of Notes in either case shall be at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. For accounting purposes, the equity conversion feature did not meet the equity classification guidance, therefore the Company elected the fair value option under ASC 825 – Financial Instruments The overall change in fair value of the Notes during the three months ended June 30, 2021, was a decrease of $51,372 (three months ended June 30, 2020, an increase of $35,694), which included contractual interest of $6,378 (three months ended June 30, 2020, interest of $6,444). Refer to Note 21 for additional details on how the fair value of the Notes is calculated. Supreme Cannabis Convertible Debentures and Accretion Debentures On October 19, 2018, Supreme Cannabis (as defined below) entered into an indenture with Computershare Trust Company of Canada (the “Trustee”) pursuant to which Supreme Cannabis issued 6.0% senior unsecured convertible debentures (the “Supreme Debentures”) for gross proceeds of $100,000. On September 9, 2020, Supreme Cannabis and the Trustee entered into a supplemental indenture to effect certain amendments to the Supreme Debentures, which included among other things: (i) the cancellation of $63,500 of principal amount of the Supreme Debentures; (ii) an increase in the interest rate to 8% per annum; (iii) the extension of the maturity date to September 10, 2025; and (iv) a reduction in the conversion price to $0.285. In addition, on September 9, 2020, Supreme Cannabis issued new senior unsecured non-convertible debentures (“Accretion Debentures”). The principal amount began at $nil and accretes at a rate of 11.06% per annum based on the remaining principal amount of the Supreme Debentures of $36,500 to a maximum of $13,500, compounding on a semi-annual basis commencing on September 9, 2020, and ending on September 9, 2023. The Accretion Debentures are payable in cash, but do not bear cash interest and are not convertible into Supreme Shares. The principal amount of the Accretion Debentures will amortize, or be paid, at 1.0% per month over the 24 months prior to maturity. As a result of the Supreme Arrangement (as defined below), the Supreme Debentures remain outstanding as securities of Supreme Cannabis, which, upon conversion will entitle the holder thereof to receive, in lieu of the number of Supreme Shares (as defined below) to which such holder was theretofore entitled, the consideration payable under the Supreme Arrangement that such holder would have been entitled to be issued and receive if, immediately prior to the effective time of the Supreme Arrangement, such holder had been the registered holder of the number of Supreme Shares to which such holder was theretofore entitled. In connection with the Supreme Arrangement, the Company, Supreme Cannabis and the Trustee entered into a supplemental indenture whereby the Company agreed to issue common shares upon conversion of any Supreme Debenture. In addition, the Company may force conversion of the Supreme Debentures outstanding with 30 days’ notice if the daily volume weighted average trading price of the Company’s common shares is greater than $38.59 for any 10 consecutive trading days. Prior to September 9, 2023, the Supreme Debentures are not redeemable. Beginning on and after September 9, 2023, Supreme Cannabis may from time to time, upon providing 60 days prior written notice to the Trustee, redeem the Convertible Debentures outstanding, provided that the Accretion Debentures have already been redeemed in full. Other revolving debt facility, loans, and financings On August 13, 2019, the Company, through its wholly owned subsidiary, Tweed Farms Inc., entered into a $40,000 revolving debt facility with Farm Credit Canada (“FCC”). The new facility replaces the previous loans with FCC and is secured by the Company’s property in Niagara-on-the-Lake. The extinguishment of $4,912 in previous FCC debt resulted in no gain or loss. The current outstanding balance of the FCC debt facility is $nil (March 31, 2021 – $nil) The revolving debt facility with FCC is secured by a first charge on the properties in Niagara-on-the-Lake, Ontario, a corporate guarantee from the Company, and a general corporate security agreement .

Other Liabilities

Other Liabilities	3 Months Ended
	Jun. 30, 2021
Other Liabilities Disclosure [Abstract]
Other Liabilities	15. OTHER LIABILITIES The components of other liabilities are as follows: As at June 30, 2021 As at March 31, 2021 Current Long-term Total Current Long-term Total Lease liabilities $ 36,862 $ 93,174 $ 130,036 $ 42,061 $ 94,164 $ 136,225 Acquisition consideration related liabilities 10,095 10,393 20,488 16,577 7,808 24,385 Refund liability 8,387 - 8,387 6,441 - 6,441 Settlement liabilities and other 13,804 5,471 19,275 41,349 5,268 46,617 $ 69,148 $ 109,038 $ 178,186 $ 106,428 $ 107,240 $ 213,668

Redeemable Noncontrolling Inter

Redeemable Noncontrolling Interest	3 Months Ended
	Jun. 30, 2021
Temporary Equity Disclosure [Abstract]
Redeemable Noncontrolling Interest	16. REDEEMABLE NONCONTROLLING INTEREST The net changes in the redeemable noncontrolling interests are as follows: Vert Mirabel BioSteel Total As at March 31, 2021 $ 11,500 $ 123,800 $ 135,300 Net income (loss) attributable to redeemable noncontrolling interest 1,293 (3,756 ) (2,463 ) Adjustments to redemption amount (1,293 ) 3,756 2,463 As at June 30, 2021 $ 11,500 $ 123,800 $ 135,300 Vert Mirabel BioSteel Total As at March 31, 2020 $ 20,250 $ 49,500 $ 69,750 Net loss attributable to redeemable noncontrolling interest (9,253 ) (1,410 ) (10,663 ) Adjustments to redemption amount 18,803 3,710 22,513 As at June 30, 2020 $ 29,800 $ 51,800 $ 81,600

Share Capital

Share Capital	3 Months Ended
	Jun. 30, 2021
Equity [Abstract]
Share Capital	17. SHARE CAPITAL CANOPY GROWTH Authorized An unlimited number of common shares. (i) Equity financings There were no equity financings during the three months ended June 30, 2021 (three months ended June 30, 2020 - none). (ii) Other issuances of common shares During the three months ended June 30, 2021, the Company issued the following shares, net of share issuance costs, as a result of business combinations, milestones being met, and other equity-settled transactions: Number of shares Share capital Share based reserve Acquisition of Supreme Cannabis 9,013,400 $ 260,668 $ - Completion of acquisition milestones 875,401 25,247 (25,692 ) Total 9,888,801 $ 285,915 $ (25,692 ) During the three months ended June 30, 2020, the Company issued the following shares, net of share issuance costs, as a result of business combinations, milestones being met, and other equity-settled transactions: Number of shares Share capital Share based reserve Completion of acquisition milestones 751,922 $ 12,079 $ (12,079 ) Other issuances 412,417 14,135 (14,719 ) Total 1,164,339 $ 26,214 $ (26,798 ) (iii) Warrants Number of whole warrants Average exercise price Warrant value Balance outstanding at March 31, 2021 1 127,073,136 $ 58.33 $ 2,568,438 Supreme Cannabis warrants 1,265,742 $ 25.61 $ 13,350 Expiry of warrants (145,831 ) 32.61 - Balance outstanding at June 30, 2021 1 128,193,047 $ 58.04 $ 2,581,788 1 Number of whole warrants Average exercise price Warrant value Balance outstanding at March 31, 2020 1 146,299,443 $ 52.44 $ 2,638,951 Exercise of warrants (18,876,901 ) 12.98 (70,266 ) Balance outstanding at June 30, 2020 1 127,422,542 $ 58.29 $ 2,568,685 1

Share-Based Compensation

Share-Based Compensation	3 Months Ended
	Jun. 30, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Share-Based Compensation	18. SHARE-BASED COMPENSATION CANOPY GROWTH CORPORATION SHARE-BASED COMPENSATION PLAN Canopy Growth's eligible employees participate in a share-based compensation plan as noted below. On September 21, 2020, the Company’s shareholders approved amendments to the Company’s Amended and Restated Omnibus Incentive Plan (as amended and restated, the “Omnibus Plan”) pursuant to which the Company can issue share-based long-term incentives. The Omnibus Plan approved by the shareholders extended the maximum term of each Option (as defined below) to be granted by the Company to ten years from the date of grant rather than six years from the date of grant. On May 27, 2021, the Board of Directors of the Company approved certain amendments to the Omnibus Plan in order to reduce the maximum number of shares available for issuance under the Omnibus Plan from 15% of the issued and outstanding shares, to 10% of the issued and outstanding shares from time to time less the number of shares issuable pursuant to other security-based compensation arrangements of the Company. All directors, officers, employees and independent contractors of the Company are eligible to receive awards of common share purchase options (“Options”), restricted share units (“RSUs”), performance share units (“PSUs”), deferred share units, stock appreciation rights, performance awards, or other shares-based awards (collectively, the “Awards”) under the Omnibus Plan. The maximum number of common shares reserved for Awards is 39,311,910 at June 30, 2021. As of June 30, 2021, the only Awards issued have been Options, RSUs and PSUs under the Omnibus Plan. The Omnibus Plan is administered by the Corporate Governance, Compensation and Nominating committee of the Company (“CGC&N Committee”) which establishes exercise prices, at not less than the market price at the date of grant, and expiry dates. Options under the Omnibus Plan generally become exercisable in increments with 1/3 Under the Company’s Employee Share Purchase Plan (the “Purchase Plan”) the aggregate number of common shares that may be issued is 600,000, and the maximum number of common shares which may be issued in any one fiscal year shall not exceed 300,000. For the three months ended June 30, 2021, no common shares were issued under the Purchase Plan. The following is a summary of the changes in the Options outstanding during the three months ended June 30, 2021: Options issued Weighted average exercise price Balance outstanding at March 31, 2021 17,704,311 $ 36.79 Options granted 560,085 30.87 Replacement options issued as a result of the acquisition of Supreme Cannabis 140,159 80.53 Options exercised (205,335 ) 17.50 Options forfeited (809,960 ) 43.79 Balance outstanding at June 30, 2021 17,389,260 $ 36.50 The following is a summary of the Options as at June 30, 2021: Options Outstanding Options Exercisable Weighted Average Weighted Average Remaining Remaining Outstanding at Contractual Life Exercisable at Contractual Life Range of Exercise Prices June 30, 2021 (years) June 30, 2021 (years) $0.06 - $24.62 2,357,356 3.15 1,407,826 2.43 $24.63 - $33.53 4,491,920 4.11 2,090,648 3.36 $33.54 - $36.80 3,405,640 3.42 2,186,429 3.42 $36.81 - $42.84 2,992,796 3.68 2,034,251 3.22 $42.85 - $171.54 4,141,548 3.64 2,469,037 3.56 17,389,260 3.65 10,188,191 3.25 At June 30, 2021, the weighted average exercise price of Options outstanding and Options exercisable was $36.50 and $37.23, respectively (March 31, 2021 – $36.79 and $36.97, respectively). The Company recorded $8,044 in share-based compensation expense related to Options issued to employees and contractors for the three months ended June 30, 2021 (three months ended June 30, 2020 – $22,328). The share-based compensation expense for the three months ended June 30, 2021 includes an amount related to 1,559,413 Options being provided in exchange for services which are subject to performance conditions (for the three months ended June 30, 2020 – During the three months ended June 30, 2021, the Company issued replacement options to employees in relation to the acquisition of Supreme Cannabis (Note 26) and recorded share-based compensation expense of $823. The Company uses the Black-Scholes option pricing model to establish the fair value of Options granted during the three months ended June 30, 2021 and 2020, on their measurement date by applying the following assumptions: June 30, June 30, 2021 2020 Risk-free interest rate 0.67% 0.33% Expected life of options (years) 3 - 5 3 - 5 Expected volatility 76% 76% Expected forfeiture rate 18% 16% Expected dividend yield nil nil Black-Scholes value of each option $17.25 $12.31 Volatility was estimated by using the historical volatility of the Company. The expected life in years represents the period of time that Options granted are expected to be outstanding. The risk-free rate was based on zero coupon Canada government bonds with a remaining term equal to the expected life of the Options. During the three months ended June 30, 2021, 205,335 Options were exercised ranging in price from $2.68 to $36.34 for gross proceeds of $3,592 (for the three months ended June 30, 2020 – For the three months ended June 30, 2021, the Company recorded $2,295, in share-based compensation expense related to RSUs (for the three months ended June 30, 2020 – $3,842). The following is a summary of the changes in the Company’s RSUs during the three months ended June 30, 2021: Number of RSUs Balance outstanding at March 31, 2021 753,310 RSUs granted 536,314 RSUs released (149,785 ) RSUs cancelled and forfeited (24,334 ) Balance outstanding at June 30, 2021 1,115,505 During the three months ended June 30, 2021, the Company recorded $1,699 (for the three months ended June 30, 2020 – $2,970), in share-based compensation expense related to acquisition milestones. During the three months ended June 30, 2021, 9,888,801 common shares, (during the three months ended June 30, 2020 – 751,922) were released on completion of acquisition milestones. At June 30, 2021, there were up to 645,509 common shares to be issued on the completion of acquisition and asset purchase milestones. In certain cases, the number of common shares to be issued is based on the volume weighted average share price at the time the milestones are met. The number of common shares has been estimated assuming the milestones were met at June 30, 2021. The number of common shares excludes common shares that are to be issued on July 4, 2023 to the previous shareholders of Spectrum Colombia S.A.S. and Canindica Capital Ltd. based on the fair market value of the Company’s Latin American business on that date. BioSteel share-based payments On October 1, 2019, the Company purchased 72% of the outstanding shares of BioSteel Sports Nutrition Inc. (“BioSteel”). BioSteel has a stock option plan under which non-transferable options to purchase common shares of BioSteel may be granted to directors, officers, employees, or independent contractors of the BioSteel. As at June 30, 2021, BioSteel had 1,549,800 (March 31, 2021 – 1,581,000) options outstanding which vest in equal tranches over a 5-year period. In determining the amount of share-based compensation related to these options, BioSteel used the Black-Scholes option pricing model to establish the fair value of options on their measurement date. The Company recorded $265 of share-based compensation expense related to the BioSteel options during the three months ended June 30, 2021 (three months ended June 30, 2020 – $244), with a corresponding increase in noncontrolling interest. RIV Capital Inc. ( “RIV Capital” ) share-based payments For the three months ended June 30, 2020, the Company recorded $1,301 in share-based compensation expense related to its former subsidiary, RIV Capital. The Company disposed of its investment in RIV Capital on February 23, 2021.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	3 Months Ended
	Jun. 30, 2021
Equity [Abstract]
Accumulated Other Comprehensive Income (Loss)	19. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) Accumulated other comprehensive income includes the following components: Foreign currency translation adjustments Changes of own credit risk of financial liabilities Accumulated other comprehensive income (loss) As at March 31, 2021 $ (28,246 ) $ (5,994 ) $ (34,240 ) Other comprehensive income (loss) (27,938 ) 660 (27,278 ) As at June 30, 2021 $ (56,184 ) $ (5,334 ) $ (61,518 ) Foreign currency translation adjustments Changes of own credit risk of financial liabilities Accumulated other comprehensive income (loss) As at March 31, 2020 $ 126,723 $ 94,176 $ 220,899 Other comprehensive loss (53,124 ) (15,360 ) (68,484 ) As at June 30, 2020 $ 73,599 $ 78,816 $ 152,415

Noncontrolling Interests

Noncontrolling Interests	3 Months Ended
	Jun. 30, 2021
Noncontrolling Interest [Abstract]
Noncontrolling Interests	20. NONCONTROLLING INTERESTS The net change in the noncontrolling interests is as follows: Vert Mirabel BioSteel Other non- material interests Total As at March 31, 2021 $ - $ 1,658 $ 3,051 $ 4,709 Comprehensive income (loss) 1,293 (3,756 ) - (2,463 ) Net (income) loss attributable to redeemable noncontrolling interest (1,293 ) 3,756 - 2,463 Share-based compensation - 265 - 265 Ownership changes - - - - Warrants - - - - As at June 30, 2021 $ - $ 1,923 $ 3,051 $ 4,974 Canopy Rivers Vert Mirabel BioSteel Other non- material interests Total As at March 31, 2020 $ 211,086 $ 7,132 $ 489 $ 3,051 $ 221,758 Comprehensive loss (3,883 ) (14,528 ) (1,410 ) - (19,821 ) Net loss attributable to redeemable noncontrolling interest - 9,253 1,410 - 10,663 Share-based compensation 1,301 - 244 - 1,545 Ownership changes 852 - - - 852 Warrants 250 - - - 250 As at June 30, 2020 $ 209,606 $ 1,857 $ 733 $ 3,051 $ 215,247

Fair Value of Financial Instrum

Fair Value of Financial Instruments	3 Months Ended
	Jun. 30, 2021
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	21. FAIR VALUE OF FINANCIAL INSTRUMENTS Fair value measurements are made using a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value: • Level 1 – defined as observable inputs such as quoted prices in active markets; • Level 2 – defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and • Level 3 – defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. The fair value measurement is categorized in its entirety by reference to its lowest level of significant input. The Company records cash, accounts receivable, interest receivable and accounts payable, and other accrued expenses and liabilities at cost. The carrying values of these instruments approximate their fair value due to their short-term maturities. Unless otherwise noted, it is management's opinion that the Company is not exposed to significant interest or credit risks arising from these financial instruments. Assets and liabilities recognized or disclosed at fair value on a nonrecurring basis may include items such as property, plant and equipment, goodwill and other intangible assets, equity and other investments and other assets. We determine the fair value of these items using Level 3 inputs, as described in the related sections below. The following table represents our financial assets and liabilities measured at estimated fair value on a recurring basis: Fair value measurement using Quoted prices Significant prices in other Significant active observable unobservable markets inputs inputs (Level 1) (Level 2) (Level 3) Total June 30, 2021 Assets: Short-term investments $ 1,491,286 $ - $ - $ 1,491,286 Restricted short-term investments 14,336 - - 14,336 Other financial assets 268 - 784,236 784,504 Liabilities: Convertible senior notes - 636,042 - 636,042 Liability arising from Acreage Arrangement - - 450,000 450,000 Warrant derivative liability - - 299,318 299,318 March 31, 2021 Assets: Short-term investments $ 1,144,563 $ - $ - $ 1,144,563 Restricted short-term investments 11,332 - - 11,332 Other financial assets 254 - 700,728 700,982 Liabilities: Convertible senior notes - 687,414 - 687,414 Liability arising from Acreage Arrangement - - 600,000 600,000 Warrant derivative liability - - 615,575 615,575 The following table summarizes the valuation techniques and significant unobservable inputs in the fair value measurement of significant level 2 financial instruments: Financial asset / financial liability Valuation techniques Key inputs Convertible senior notes Convertible note pricing model Quoted prices in over-the-counter broker market The following table summarizes the valuation techniques and significant unobservable inputs in the fair value measurement of significant level 3 financial instruments: Financial asset / financial liability Valuation techniques Significant unobservable inputs Relationship of unobservable inputs to fair value Acreage financial instrument Probability weighted expected return model Probability of each scenario Change in probability of occurrence in each scenario will result in a change in fair value Number of common shares to be issued Increase or decrease in value and number of common shares will result in a decrease or increase in fair value Probability and timing of US legalization Increase or decrease in probability of US legalization will result in an increase or decrease in fair value Estimated premium on US legalization Increase or decrease in estimated premium on US legalization will result in an increase or decrease in fair value Control premium Increase or decrease in estimated control premium will result in an increase or decrease in fair value Market access premium Increase or decrease in estimated market access premium will result in an increase or decrease in fair value TerrAscend Exchangeable Shares, TerrAscend Option Put option pricing model Probability and timing of US legalization Increase or decrease in probability of US legalization will result in an increase or decrease in fair value Hempco Debenture Discounted cash flow Discount rate Increase or decrease in discount rate will result in a decrease or increase in fair value TerrAscend warrants - October 2019, March 2020, December 2020 Monte Carlo simulation model Probability and timing of US legalization Increase or decrease in probability of US legalization will result in an increase or decrease in fair value Arise Bioscience term loan, TerrAscend Canada term loan - Discounted cash flow Probability and timing of US legalization Increase or decrease in probability of US legalization will result in an increase or decrease in fair value October 2019, March 2020 Discount rate Increase or decrease in discount rate will result in a decrease or increase in fair value SLANG Worldwide Warrant Black-Sholes option pricing model Probability and timing of US legalization Increase or decrease in probability of US legalization will result in an increase or decrease in fair value Warrant derivative liability Monte Carlo simulation model Volatility of Canopy Growth share price Increase or decrease in volatility will result in an increase or decrease in fair value BioSteel redeemable NCI Discounted cash flow Discount rate Increase or decrease in discount rate will result in a decrease or increase in fair value Future wholesale price and production levels Increase or decrease in future wholesale price and production levels will result in an increase or decrease in fair value Vert Mirabel redeemable noncontrolling interest Discounted cash flow Discount rate Increase or decrease in discount rate will result in a decrease or increase in fair value Future wholesale price and production levels Increase or decrease in future wholesale price and production levels will result in an increase or decrease in fair value During the three months ended June 30, 2021 and June 30, 2020, there were no transfers of amounts between levels

Revenue

Revenue	3 Months Ended
	Jun. 30, 2021
Revenue From Contract With Customer [Abstract]
Revenue	22. REVENUE Revenue is dissaggregated as follows: Three months ended June 30, June 30, 2021 2020 Canadian recreational cannabis net revenue Business-to-business 1 $ 42,693 $ 34,934 Business-to-consumer 17,344 9,330 60,037 44,264 Canadian medical cannabis net revenue 2 13,492 13,910 73,529 58,174 International and other revenue C 3 11,443 15,369 Other 7,967 5,739 19,410 21,108 Global cannabis net revenue 92,939 79,282 Other consumer products Storz & Bickel 24,070 17,120 This Works 6,551 6,049 BioSteel 6,661 2,448 Other 5,988 5,517 Other consumer products revenue 43,270 31,134 Net revenue $ 136,209 $ 110,416 1 – $7,246). 2 The Company recognizes variable consideration related to estimated future product returns and price adjustments as a reduction of the transaction price at the time revenue for the corresponding product sale is recognized. Net revenue reflects actual returns and variable consideration related to estimated returns and price adjustments in the amount of $3,000 for the three months ended June 30, 2021 (three months ended June 30, 2020 – $3,400). As of June 30, 2021, the liability for estimated returns and price adjustments was $8,387 (March 31, 2021 – $6,441).

Other Income (Expense), Net

Other Income (Expense), Net	3 Months Ended
	Jun. 30, 2021
Other Income And Expenses [Abstract]
Other Income (Expense), Net	23. OTHER INCOME (EXPENSE), NET Other income (expense), net is dissaggregated as follows: Three months ended June 30, June 30, 2021 2020 Fair value changes on other financial assets $ 84,152 $ 21,807 Fair value changes on liability arising from Acreage Arrangement 150,000 (35,000 ) Fair value changes on convertible senior notes 50,712 (20,334 ) Fair value change on warrant derivative liability 316,257 35,369 Fair value changes on acquisition related contingent consideration (199 ) 39,983 Interest income 2,647 8,993 Interest expense (24,564 ) (1,155 ) Foreign currency loss 1,030 (5,959 ) Loss on disposal of consolidated entity (2,339 ) - Other income (expense), net 2,970 4,501 $ 580,666 $ 48,205

Income Taxes

Income Taxes	3 Months Ended
	Jun. 30, 2021
Income Tax Disclosure [Abstract]
Income Taxes	24. INCOME TAXES There have been no material changes to income tax matters in connection with normal course operations during the three months ended June 30, 2021. The Company is subject to income tax in numerous jurisdictions with varying income tax rates. During the most recent period ended and the fiscal year to date, there were no material changes to the statutory income tax rates in the taxing jurisdictions where the majority of the Company’s income for tax purposes was earned, or where its temporary differences or losses are expected to be realized or settled. Although statutory income tax rates remain stable, the Company’s effective income tax rate may fluctuate, arising as a result of the Company’s evolving footprint, discrete transactions and other factors that, to the extent material, are disclosed in these financial statements. The Company continues to believe that the amount of unrealized tax benefits appropriately reflects the uncertainty of items that are or may in the future be under discussion, audit, dispute or appeal with a tax authority or which otherwise result in uncertainty in the determination of income for tax purposes. If appropriate, an unrealized tax benefit will be realized in the reporting period in which the Company determines that realization is not in doubt. Where the final determined outcome is different from the Company’s estimate, such difference will impact the Company’s income taxes in the reporting period during which such determination is made.

Acquisitions

Acquisitions	3 Months Ended
	Jun. 30, 2021
Business Combinations [Abstract]
Acquisitions	26. ACQUISITIONS The following table summarizes the consolidated balance sheet impact at acquisition of the Company’s business combinations that occurred in the three months ended June 30, 2021: Ace Supreme Valley Cannabis (i) (ii) Total Cash and cash equivalents $ 1,544 $ 41,306 $ 42,850 Inventory 878 33,681 34,559 Other current assets 2,249 15,145 17,394 Property, plant and equipment 105 179,123 179,228 Intangible assets Brands 14,000 20,900 34,900 Distribution channel - 3,000 3,000 Operating licenses - 10,500 10,500 Goodwill 36,464 85,910 122,374 Accounts payable and other accrued expenses and liabilities (1,148 ) (13,258 ) (14,406 ) Debt and other liabilities - (90,482 ) (90,482 ) Deferred income tax liabilities - (6,157 ) (6,157 ) Net assets acquired $ 54,092 $ 279,668 $ 333,760 Consideration paid in cash $ 51,623 $ 84 $ 51,707 Consideration paid in shares - 260,668 260,668 Replacement options - 629 629 Replacement warrants - 13,350 13,350 Other consideration 2,469 4,937 7,406 Total consideration $ 54,092 $ 279,668 $ 333,760 Consideration paid in cash $ 51,623 $ 84 $ 51,707 Less: Cash and cash equivalents acquired (1,544 ) (41,306 ) (42,850 ) Net cash outflow (inflow) $ 50,079 $ (41,222 ) $ 8,857 The table above summarizes the fair value of the consideration given and the fair values assigned to the assets acquired and liabilities assumed for each acquisition. Goodwill arose in these acquisitions because the cost of acquisition included a control premium. In addition, the consideration paid for the combination reflected the benefit of expected revenue growth and future market development. These benefits were not recognized separately from goodwill because they do not meet the recognition criteria for identifiable intangible assets. None of the goodwill arising on these acquisitions is expected to be deductible in the computation of income for tax purposes. (i) Ace Valley On April 1, 2021, the Company entered into a share purchase agreement (the “AV Share Purchase Agreement”) with Tweed Inc., AV Cannabis Inc. (“Ace Valley”), and the shareholders of Ace Valley (the “AV Vendors”) pursuant to which the Company indirectly acquired 100% of the issued and outstanding shares of Ace Valley for cash consideration of $51,623. Ace Valley is an Ontario-based cannabis brand with a focus on premium, ready-to-enjoy products including vapes, pre-roll joints and gummies. Pursuant to the terms of the AV Share Purchase Agreement, the Company may be required to make certain earn-out payments to the AV Vendors, which may result in an additional cash payment or the issuance of common shares, subject to the fulfillment of certain conditions by April 1, 2023. This represents liability-classified contingent consideration. Management has estimated the fair value of this consideration to be $2,469 by assessing the probability and timing of the fulfillment of the specified conditions and discounting the expected cash outflows to present value. Due to the timing of this acquisition, the purchase price allocation for the acquisition of Ace Valley is provisional. The fair value assigned to the consideration paid, intangible assets and net assets acquired is based on management’s best estimate using the information currently available and may be revised by the Company as additional information is received. (ii) Supreme Cannabis On June 22, 2021, the Company and the Supreme Cannabis Company, Inc. (“Supreme Cannabis”) completed an arrangement (the “Supreme Arrangement”) pursuant to which the Company acquired 100% of the issued and outstanding common shares of Supreme Cannabis (the “Supreme Shares”). Supreme Cannabis is a producer of recreational, wholesale and medical cannabis products, with a diversified portfolio of distinct cannabis companies, products and brands. Pursuant to the Supreme Arrangement, the Company issued 9,013,400 common shares with a fair value on closing of $260,668 and made a cash payment of $84 to former Supreme Cannabis shareholders in consideration for their Supreme Shares. The Company also assumed the obligation to issue 1,265,742 common shares upon the exercise of outstanding warrants of Supreme Cannabis and issued 140,159 replacement options. The fair value of the obligation upon the exercise of the outstanding warrants of Supreme Cannabis was estimated to be $13,350 using a Black-Scholes model. The replacement options’ fair value totaled $1,452, calculated using a Black-Scholes model, of which $629 was included in consideration paid as it related to pre-combination services and the residual $823 fair value was recognized immediately in share-based compensation expense after the completion of the acquisition. On June 22, 2021, Supreme Cannabis had convertible debentures outstanding with a principal amount of $26,968 which were convertible into 94,625,183 Supreme Shares. As a result of the acquisition the conversion feature was adjusted in accordance with an exchange ratio of 0.011659. The fair value of these convertible debentures on June 22, 2021 was estimated to be $36,751, of which $4,937 was allocated to the conversion feature and $31,814 to the debt component. Due to the timing of this acquisition, the purchase price allocation for the acquisition of Supreme Cannabis is provisional. The fair value assigned to the consideration paid, intangible assets and net assets acquired is based on management’s best estimate using the information currently available and may be revised by the Company as additional information is received.

Acreage Arrangement and Amendme

Acreage Arrangement and Amendments to Cbi Investor Rights Agreement and Warrants	3 Months Ended
	Jun. 30, 2021
Business Combinations [Abstract]
Acreage Arrangement and Amendments to Cbi Investor Rights Agreement and Warrants	27. ACREAGE ARRANGEMENT AND AMENDMENTS TO CBI INVESTOR RIGHTS AGREEMENT AND WARRANTS Acreage Arrangement On September 23, 2020, the Company and Acreage Holdings, Inc. (“Acreage”) entered into a second amendment (the “Acreage Amending Agreement”) to the arrangement agreement (the “Acreage Arrangement Agreement”) between the Company and Acreage dated April 18, 2019, as amended on May 15, 2019, and implemented an amended and restated plan of arrangement (the “Acreage Amended Arrangement”). The Acreage Amended Arrangement provides for, among other things, the following: • Following the occurrence or waiver (at the discretion of Canopy Growth) of changes in U.S. federal law to permit the general cultivation, distribution, and possession of marijuana or to remove the regulation of such activities from the federal laws of the United States (the “Triggering Event”) and subject to the satisfaction or waiver of the conditions set out in the Acreage Arrangement Agreement (as modified in connection with the Acreage Amending Agreement), Canopy Growth will acquire all of the issued and outstanding Class E subordinated voting shares (the “Fixed Shares”) based on an amended exchange ratio equal to 0.3048 of a common share to be received for each Fixed Share held. The foregoing exchange ratio for the Fixed Shares is subject to adjustment in accordance with the Acreage Amended Arrangement if, among other things, Acreage issues greater than the permitted number of Fixed Shares; • Upon the occurrence or waiver (at the discretion of Canopy Growth) of the Triggering Event, Canopy Growth will have the right exercisable for a period of 30 days, to acquire all of the issued and outstanding Class D subordinated voting shares (the “Floating Shares”) for cash or common shares or a combination thereof, in Canopy Growth’s sole discretion at a price equal to the 30-day volume weighted average trading price of the Floating Shares on the Canadian Securities Exchange, subject to a minimum call price of US$6.41 per Floating Share. The foregoing exchange ratio for the Floating Shares is subject to adjustment in accordance with the Acreage Amended Arrangement if Acreage issues greater than the permitted number of Floating Shares. The acquisition of the Floating Shares, if acquired, will take place concurrently with the closing of the acquisition of the Fixed Shares; • Immediately prior to the acquisition of the Fixed Shares, each issued and outstanding Class F multiple voting share will automatically be exchanged for one Fixed Share and thereafter be acquired by Canopy Growth upon the same terms and conditions as the acquisition of the Fixed Shares; • If the occurrence or waiver of the Triggering Event does not occur by September 23, 2030, Canopy Growth’s rights to acquire both the Fixed Shares and the Floating Shares will terminate; • Upon implementation of the Acreage Amended Arrangement, Canopy Growth made a cash payment to the shareholders of Acreage and holders of certain convertible securities in the aggregate amount of US$37,500 ($49,849); and • Acreage is only permitted to issue an aggregate of up to 32,700,000 Fixed Shares and Floating Shares. At June 30, 2021, the right and the obligation (the “Acreage financial instrument”) to acquire the Fixed Shares represents a financial liability of $450,000 (March 31, 2021 – $600,000), as the estimated fair value of the Acreage business is less than the estimated fair value of the consideration to be provided upon the exercise of the Acreage financial instrument. Fair value changes of $150,000 were recognized in other income (expense), net in the three months ended June 30, 2021 (three months ended June 30, 2020 – $35,000) (see Note 23). The fair value determination includes a high degree of subjectivity and judgment, which results in significant estimation uncertainty. See Note 21 for additional details on how the fair value of the Acreage financial instrument is calculated on a recurring basis. From a measurement perspective, the Company has elected the fair value option under ASC 825. In connection with the Acreage Amended Arrangement, on September 23, 2020, an affiliate of the Company advanced US$50,000 ($66,995) to Universal Hemp, LLC, a wholly-owned subsidiary of Acreage (“Acreage Hempco”) pursuant to a secured debenture (“debenture”). In accordance with the terms of the debenture, the funds cannot be used, directly or indirectly, in connection with or for any cannabis or cannabis-related operations in the United States, unless and until such operations comply with all applicable laws of the United States. The debenture bears interest at a rate of 6.1% per annum, matures on September 23, 2030, or such earlier date in accordance with the terms of the debenture, and all interest payments made pursuant to the debenture are payable in cash by Acreage Hempco. The debenture is not convertible and is not guaranteed by Acreage. The amount advanced on September 23, 2020 pursuant to the debenture has been recorded in other financial assets (see Note 9), and the Company has elected the fair value option under ASC 825 (see Note 21). At June 30, 2021, the estimated fair value of the debenture issued to an affiliate of the Company by Acreage Hempco was $28,391 (March 31, 2021 – $27,448), measured using a discounted cash flow model, and fair value changes and foreign currency translation adjustments totaling $943 were recognized in other income (expense), net in the three months ended June 30, 2021 (see Note 23). An additional US$50,000 may be advanced pursuant to the debenture subject to the satisfaction of certain conditions by Acreage Hempco. Amendment to the CBI Investor Rights Agreement and warrants On April 18, 2019, certain wholly-owned subsidiaries of CBI and Canopy Growth entered into a second amended and restated investor rights agreement and a consent agreement. In connection with these agreements, on June 27, 2019, Canopy Growth (i) extended the term of the first tranche of warrants, which allow CBI to acquire 88.5 million additional shares of Canopy Growth for a fixed price of $50.40 per share (the “Tranche A Warrants”), to November 1, 2023; and (ii) replaced the second tranche of warrants with two new tranches of warrants (the “Tranche B Warrants” and the “Tranche C Warrants”) as follows: • the Tranche B Warrants are exercisable to acquire 38.5 million common shares at a price of C$76.68 per common share; and • the Tranche C Warrants are exercisable to acquire 12.8 million common shares at a price equal to the 5-day volume-weighted average price of the common shares immediately prior to exercise. In connection with the Tranche B Warrants and the Tranche C Warrants, Canopy Growth will provide CBI with a share repurchase credit of up to $1.583 billion on the aggregate exercise price of the Tranche B Warrants and Tranche C Warrants in the event that Canopy Growth does not purchase for cancellation the lesser of (i) 27,378,866 common shares; and (ii) common shares with a value of $1.583 billion, during the period commencing on April 18, 2019 and ending on the date that is 24 months after the date that CBI exercises all of the Tranche A Warrants. The share repurchase credit feature is accounted for as a derivative liability, with the fair value continuing to be $nil at June 30, 2021. The modifications to the Tranche A Warrants resulted in them meeting the definition of a derivative instrument under ASC 815 - Derivatives and Hedging The Tranche B Warrants are accounted for as derivative instruments measured at fair value in accordance with ASC 815. At June 30, 2021, the fair value of the warrant derivative liability was $299,318 (March 31, 2021 – $615,575), and fair value changes of $316,257 have been recognized in other income (expense), net in the three months ended June 30, 2021 (three months ended June 30, 2020 – gain of $35,369) (see Note 23). The fair value determination includes a high degree of subjectivity and judgment, which results in significant estimation uncertainty. See Note 21 for additional details on how the fair value of the warrant derivative liability is calculated on a recurring basis. The Tranche C Warrants are accounted for as derivative instruments, with the fair value continuing to be $nil at June 30, 2021.

Segment Information

Segment Information	3 Months Ended
	Jun. 30, 2021
Segment Reporting [Abstract]
Segment Information	28. SEGMENT INFORMATION Reportable segments The Company is reporting its financial results for the following two operating segments, which are also its reportable segments: (i) global cannabis, and (ii) other consumer products. These segments reflect how the Company’s operations are managed, how the Company’s Chief Executive Officer, who is the chief operating decision maker (“CODM”), allocates resources and evaluates performance, and how the Company’s internal management financial reporting is structured. The Company’s global cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Company’s other consumer products segment comprises the production, distribution and sale of consumer products, including (i) Storz & Bickel vaporizers; (ii) This Works beauty, skincare, wellness and sleep products; (iii) BioSteel sports nutrition beverages, mixes, protein, gum and mints; and (iv) other revenue sources. The Company’s CODM evaluates the performance of these two segments focusing on (i) segment net revenue, and (ii) segment gross margin and gross margin percentage as the measure of segment profit or loss. Accordingly, information regarding segment net revenue and segment gross margin for the comparative periods has been recast to reflect the aforementioned change in reportable segments. Three months ended June 30, June 30, 2021 2020 Segmented net revenue Global cannabis $ 92,939 $ 79,282 Other consumer products 43,270 31,134 $ 136,209 $ 110,416 Segmented gross margin: Global cannabis $ 13,369 $ (6,858 ) Other consumer products 13,869 13,353 27,238 6,495 Selling, general and administrative expenses 112,574 135,392 Share-based compensation 13,126 30,685 Asset impairment and restructuring costs 89,249 12,794 Operating loss (187,711 ) (172,376 ) Loss from equity method investments (100 ) (7,189 ) Other income (expense), net 580,666 48,205 Net income (loss) before incomes taxes $ 392,855 $ (131,360 ) Asset information by segment is not provided to, or reviewed by, the Company’s CODM as it is not used to make strategic decisions, allocate resources, or assess performance. Entity-wide disclosures Disaggregation of net revenue by geographic area: Three months ended June 30, June 30, 2021 2020 Canada $ 82,612 $ 65,717 Germany 26,106 27,997 United States 19,867 10,445 Other 7,624 6,257 $ 136,209 $ 110,416 Disaggregation of property, plant and equipment by geographic area: June 30, March 31, 2021 2021 Canada $ 931,042 $ 847,678 United States 143,283 143,747 Other 68,289 83,112 $ 1,142,614 $ 1,074,537 For the three months ended June 30, 2021, one customer represented more than 10% of the Company’s net revenue (three months ended June 30, 2020 – one).

Summary of Significant Accounti

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Principles of consolidation	Principles of consolidation The accompanying condensed interim consolidated financial statements include the accounts of the Company and all entities in which the Company either has a controlling voting interest or is the primary beneficiary of a variable interest entity. All intercompany accounts and transactions have been eliminated on consolidation. Information on the Company’s subsidiaries with noncontrolling interests is included in Note 20.
Use of estimates	Use of estimates The preparation of these condensed interim consolidated financial statements and accompanying notes in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ from those estimates.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements Income Taxes In December 2019, the Financial Accounting Standards Board (“FASB”) issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes period, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The Company adopted ASU 2019-12 as of April 1, 202 1 . There was no impact of adopting ASU 2019-12 on the condensed interim consolidated financial statements. Investments-Equity Securities In January 2020, the FASB issued ASU 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) Accounting Guidance not yet adopted Convertible Instruments and Contracts in an Entity’s Own Equity In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40):Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity simplifies the accounting for convertible instruments by reducing the number of accounting models for convertible debt instruments and convertible preferred stock. In addition, ASU 2020-06 enhances information transparency by making targeted improvements to the disclosures for convertible instruments and earnings-per-share (EPS) guidance and amends the guidance for the derivatives scope exception for contracts in an entity’s own equity to reduce form-over-substance-based accounting conclusions. ASU 2020-06 is effective for interim and annual periods beginning after December 15, 2021, with early adoption permitted after December 15, 2020.

Cash and Cash Equivalents (Tabl

Cash and Cash Equivalents (Tables)	3 Months Ended
	Jun. 30, 2021
Cash And Cash Equivalents [Abstract]
Components of Cash and Cash Equivalents	The components of cash and cash equivalents are as follows: June 30, March 31, 2021 2021 Cash $ 367,284 $ 436,588 Cash equivalents 192,556 718,065 $ 559,840 $ 1,154,653

Short-term Investments (Tables)

Short-term Investments (Tables)	3 Months Ended
	Jun. 30, 2021
Short Term Investments [Abstract]
Components of Short-term Investments	The components of short-term investments are as follows: June 30, March 31, 2021 2021 Term deposits $ 442,916 $ 463,824 Government securities 92,360 136,620 Asset-backed securities 252,848 16,342 Commercial paper and other 703,162 527,777 $ 1,491,286 $ 1,144,563

Amounts Receivable, Net (Tables

Amounts Receivable, Net (Tables)	3 Months Ended
	Jun. 30, 2021
Receivables [Abstract]
Components of Amounts Receivable, Net	The components of amounts receivable, net are as follows: June 30, March 31, 2021 2021 Accounts receivable, net $ 87,582 $ 67,106 Indirect taxes receivable 8,674 8,281 Interest receivable 6,052 5,140 Other receivables 4,147 11,908 $ 106,455 $ 92,435

Inventory (Tables)

Inventory (Tables)	3 Months Ended
	Jun. 30, 2021
Inventory Disclosure [Abstract]
Components of Inventory	The components of inventory are as follows: June 30, March 31, 2021 2021 Raw materials, packaging supplies and consumables $ 66,006 $ 55,554 Work in progress 219,816 223,652 Finished goods 125,853 88,773 $ 411,675 $ 367,979

Prepaid Expenses and Other As_2

Prepaid Expenses and Other Assets (Tables)	3 Months Ended
	Jun. 30, 2021
Prepaid Expense And Other Assets Current [Abstract]
Components of Prepaid and Other Assets	The components of prepaid expenses and other assets are as follows: June 30, March 31, 2021 2021 Prepaid expenses $ 44,412 $ 28,349 Deposits 21,008 18,316 Prepaid inventory 1,157 1,496 Other assets 25,007 19,071 $ 91,584 $ 67,232

Other Financial Assets (Tables)

Other Financial Assets (Tables)	3 Months Ended
	Jun. 30, 2021
Schedule Of Investments [Abstract]
Summary of Changes in Other Financial Assets	The following table outlines changes in other financial assets. Additional details on how the fair value of significant investments is calculated are included in Note 21. Foreign Exercise of Balance at currency options / Balance at March 31, Fair value translation disposal June 30, Entity Instrument 2021 changes adjustments of shares 2021 TerrAscend Exchangeable Shares Exchangeable shares $ 385,000 $ 53,000 $ - $ - $ 438,000 TerrAscend Canada - October 2019 Term loan / debenture 10,240 540 - - 10,780 TerrAscend Canada - March 2020 Term loan / debenture 56,330 3,350 - - 59,680 Arise Bioscience Term loan / debenture 13,077 1,376 (171 ) - 14,282 TerrAscend - October 2019 Warrants 17,250 2,780 - - 20,030 TerrAscend - March 2020 Warrants 152,910 22,820 - - 175,730 TerrAscend - December 2020 Warrants 13,240 1,840 - - 15,080 TerrAscend Option 10,600 1,500 - - 12,100 Acreage Hempco 1 Debenture 27,448 1,302 (359 ) - 28,391 SLANG Warrants 9,400 (4,000 ) - - 5,400 Other - at fair value through net income (loss) Various 5,487 (356 ) - (100 ) 5,031 Other - classified as held for investment Loan receivable 7,185 - - (31 ) 7,154 $ 708,167 $ 84,152 $ (530 ) $ (131 ) $ 791,658 1

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	3 Months Ended
	Jun. 30, 2021
Property Plant And Equipment [Abstract]
Summary of Expected Useful Life of Property, Plant and Equipment	The components of property, plant and equipment are as follows: June 30, March 31, 2021 2021 Buildings and greenhouses $ 833,426 $ 651,166 Production and warehouse equipment 210,671 216,925 Leasehold improvements 101,163 106,837 Office and lab equipment 35,053 30,546 Land 33,158 34,747 Computer equipment 22,719 26,431 Right-of-use-assets Buildings and greenhouses 100,530 100,517 Production and warehouse equipment 530 530 Assets in process 26,653 129,428 1,363,903 1,297,127 Less: Accumulated depreciation (221,289 ) (222,590 ) $ 1,142,614 $ 1,074,537

Intangible Assets (Tables)

Intangible Assets (Tables)	3 Months Ended
	Jun. 30, 2021
Intangible Assets Net Excluding Goodwill [Abstract]
Summary of Components of Intangible Assets	The components of intangible assets are as follows: June 30, 2021 March 31, 2021 Gross Net Gross Net Carrying Carrying Carrying Carrying Amount Amount Amount Amount Finite lived intangible assets Intellectual property $ 211,069 $ 165,077 $ 212,100 $ 168,655 Distribution channel 76,599 35,208 73,756 35,176 Software and domain names 29,655 18,193 27,836 18,149 Brands 21,102 7,241 21,812 8,894 Operating licenses 10,500 10,500 - - Amortizable intangibles in process 875 875 1,952 1,952 Total $ 349,800 $ 237,094 $ 337,456 $ 232,826 Indefinite lived intangible assets Acquired brands $ 101,969 $ 67,341 Operating licenses 8,000 8,000 Total intangible assets $ 347,063 $ 308,167

Goodwill (Tables)

Goodwill (Tables)	3 Months Ended
	Jun. 30, 2021
Goodwill And Intangible Assets Disclosure [Abstract]
Changes in Carrying Amount of Goodwill	The changes in the carrying amount of goodwill are as follows: Balance, March 31, 2020 $ 1,954,471 Foreign currency translation adjustments (65,117 ) Balance, March 31, 2021 $ 1,889,354 Purchase accounting allocations 122,374 Disposal of consolidated entities (5,245 ) Foreign currency translation adjustments (6,025 ) Balance, June 30, 2021 $ 2,000,458

Other Accrued Expenses and Li_2

Other Accrued Expenses and Liabilities (Tables)	3 Months Ended
	Jun. 30, 2021
Accounts Payable And Accrued Liabilities Current [Abstract]
Components of Other Accrued Expenses and Liabilities	The components of other accrued expenses and liabilities are as follows: June 30, March 31, 2021 2021 Employee compensation $ 36,061 $ 47,237 Taxes and government fees 14,250 13,550 Professional fees 7,303 11,544 Other 22,324 28,482 $ 79,938 $ 100,813

Debt (Tables)

Debt (Tables)	3 Months Ended
	Jun. 30, 2021
Debt Disclosure [Abstract]
Summary of Components of Debt	The components of debt are as follows: June 30, March 31, Maturity Date 2021 2021 Convertible senior notes at 4.25% interest with semi-annual interest payments July 15, 2023 Principal amount $ 600,000 $ 600,000 Accrued interest 12,042 5,664 Non-credit risk fair value adjustment 52,620 109,710 Credit risk fair value adjustment (28,620 ) (27,960 ) 636,042 687,414 Convertible debentures September 10, 2025 30,532 - Accretion debentures September 10, 2025 9,802 - Credit facility March 18, 2026 880,927 891,677 Other revolving debt facility, loan, and financings 3,475 3,872 1,560,778 1,582,963 Less: current portion (15,705 ) (9,827 ) Long-term portion $ 1,545,073 $ 1,573,136

Other Liabilities (Tables)

Other Liabilities (Tables)	3 Months Ended
	Jun. 30, 2021
Other Liabilities Disclosure [Abstract]
Components of Other Liabilities	The components of other liabilities are as follows: As at June 30, 2021 As at March 31, 2021 Current Long-term Total Current Long-term Total Lease liabilities $ 36,862 $ 93,174 $ 130,036 $ 42,061 $ 94,164 $ 136,225 Acquisition consideration related liabilities 10,095 10,393 20,488 16,577 7,808 24,385 Refund liability 8,387 - 8,387 6,441 - 6,441 Settlement liabilities and other 13,804 5,471 19,275 41,349 5,268 46,617 $ 69,148 $ 109,038 $ 178,186 $ 106,428 $ 107,240 $ 213,668

Redeemable Noncontrolling Int_2

Redeemable Noncontrolling Interest (Tables)	3 Months Ended
	Jun. 30, 2021
Temporary Equity Disclosure [Abstract]
Summary of Net Change in Redeemable Noncontrolling Interests	The net changes in the redeemable noncontrolling interests are as follows: Vert Mirabel BioSteel Total As at March 31, 2021 $ 11,500 $ 123,800 $ 135,300 Net income (loss) attributable to redeemable noncontrolling interest 1,293 (3,756 ) (2,463 ) Adjustments to redemption amount (1,293 ) 3,756 2,463 As at June 30, 2021 $ 11,500 $ 123,800 $ 135,300 Vert Mirabel BioSteel Total As at March 31, 2020 $ 20,250 $ 49,500 $ 69,750 Net loss attributable to redeemable noncontrolling interest (9,253 ) (1,410 ) (10,663 ) Adjustments to redemption amount 18,803 3,710 22,513 As at June 30, 2020 $ 29,800 $ 51,800 $ 81,600

Share Capital (Tables)

Share Capital (Tables)	3 Months Ended
	Jun. 30, 2021
Equity [Abstract]
Summary of Issuances of Stock Other	During the three months ended June 30, 2021, the Company issued the following shares, net of share issuance costs, as a result of business combinations, milestones being met, and other equity-settled transactions: Number of shares Share capital Share based reserve Acquisition of Supreme Cannabis 9,013,400 $ 260,668 $ - Completion of acquisition milestones 875,401 25,247 (25,692 ) Total 9,888,801 $ 285,915 $ (25,692 ) During the three months ended June 30, 2020, the Company issued the following shares, net of share issuance costs, as a result of business combinations, milestones being met, and other equity-settled transactions: Number of shares Share capital Share based reserve Completion of acquisition milestones 751,922 $ 12,079 $ (12,079 ) Other issuances 412,417 14,135 (14,719 ) Total 1,164,339 $ 26,214 $ (26,798 )
Summary of Warrants	Number of whole warrants Average exercise price Warrant value Balance outstanding at March 31, 2021 1 127,073,136 $ 58.33 $ 2,568,438 Supreme Cannabis warrants 1,265,742 $ 25.61 $ 13,350 Expiry of warrants (145,831 ) 32.61 - Balance outstanding at June 30, 2021 1 128,193,047 $ 58.04 $ 2,581,788 1 Number of whole warrants Average exercise price Warrant value Balance outstanding at March 31, 2020 1 146,299,443 $ 52.44 $ 2,638,951 Exercise of warrants (18,876,901 ) 12.98 (70,266 ) Balance outstanding at June 30, 2020 1 127,422,542 $ 58.29 $ 2,568,685 1

Share-Based Compensation (Table

Share-Based Compensation (Tables)	3 Months Ended
	Jun. 30, 2021
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Summary of Outstanding Stock Options	The following is a summary of the Options as at June 30, 2021: Options Outstanding Options Exercisable Weighted Average Weighted Average Remaining Remaining Outstanding at Contractual Life Exercisable at Contractual Life Range of Exercise Prices June 30, 2021 (years) June 30, 2021 (years) $0.06 - $24.62 2,357,356 3.15 1,407,826 2.43 $24.63 - $33.53 4,491,920 4.11 2,090,648 3.36 $33.54 - $36.80 3,405,640 3.42 2,186,429 3.42 $36.81 - $42.84 2,992,796 3.68 2,034,251 3.22 $42.85 - $171.54 4,141,548 3.64 2,469,037 3.56 17,389,260 3.65 10,188,191 3.25
Summary of Assumptions Applied to Establish Fair Value of Options Granted Using Black-Scholes Option Pricing Model	The Company uses the Black-Scholes option pricing model to establish the fair value of Options granted during the three months ended June 30, 2021 and 2020, on their measurement date by applying the following assumptions: June 30, June 30, 2021 2020 Risk-free interest rate 0.67% 0.33% Expected life of options (years) 3 - 5 3 - 5 Expected volatility 76% 76% Expected forfeiture rate 18% 16% Expected dividend yield nil nil Black-Scholes value of each option $17.25 $12.31
Summary of Changes in RSUs	The following is a summary of the changes in the Company’s RSUs during the three months ended June 30, 2021: Number of RSUs Balance outstanding at March 31, 2021 753,310 RSUs granted 536,314 RSUs released (149,785 ) RSUs cancelled and forfeited (24,334 ) Balance outstanding at June 30, 2021 1,115,505
Omnibus Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Summary of Changes in Employee Stock Options	The following is a summary of the changes in the Options outstanding during the three months ended June 30, 2021: Options issued Weighted average exercise price Balance outstanding at March 31, 2021 17,704,311 $ 36.79 Options granted 560,085 30.87 Replacement options issued as a result of the acquisition of Supreme Cannabis 140,159 80.53 Options exercised (205,335 ) 17.50 Options forfeited (809,960 ) 43.79 Balance outstanding at June 30, 2021 17,389,260 $ 36.50

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Loss) (Tables)	3 Months Ended
	Jun. 30, 2021
Equity [Abstract]
Accumulated Other Comprehensive Income	Accumulated other comprehensive income includes the following components: Foreign currency translation adjustments Changes of own credit risk of financial liabilities Accumulated other comprehensive income (loss) As at March 31, 2021 $ (28,246 ) $ (5,994 ) $ (34,240 ) Other comprehensive income (loss) (27,938 ) 660 (27,278 ) As at June 30, 2021 $ (56,184 ) $ (5,334 ) $ (61,518 ) Foreign currency translation adjustments Changes of own credit risk of financial liabilities Accumulated other comprehensive income (loss) As at March 31, 2020 $ 126,723 $ 94,176 $ 220,899 Other comprehensive loss (53,124 ) (15,360 ) (68,484 ) As at June 30, 2020 $ 73,599 $ 78,816 $ 152,415

Noncontrolling Interests (Table

Noncontrolling Interests (Tables)	3 Months Ended
	Jun. 30, 2021
Noncontrolling Interest [Abstract]
Summary of Net Change in Noncontrolling Interests	The net change in the noncontrolling interests is as follows: Vert Mirabel BioSteel Other non- material interests Total As at March 31, 2021 $ - $ 1,658 $ 3,051 $ 4,709 Comprehensive income (loss) 1,293 (3,756 ) - (2,463 ) Net (income) loss attributable to redeemable noncontrolling interest (1,293 ) 3,756 - 2,463 Share-based compensation - 265 - 265 Ownership changes - - - - Warrants - - - - As at June 30, 2021 $ - $ 1,923 $ 3,051 $ 4,974 Canopy Rivers Vert Mirabel BioSteel Other non- material interests Total As at March 31, 2020 $ 211,086 $ 7,132 $ 489 $ 3,051 $ 221,758 Comprehensive loss (3,883 ) (14,528 ) (1,410 ) - (19,821 ) Net loss attributable to redeemable noncontrolling interest - 9,253 1,410 - 10,663 Share-based compensation 1,301 - 244 - 1,545 Ownership changes 852 - - - 852 Warrants 250 - - - 250 As at June 30, 2020 $ 209,606 $ 1,857 $ 733 $ 3,051 $ 215,247

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	3 Months Ended
	Jun. 30, 2021
Summary of Financial Assets and Liabilities Measured at Estimated Fair Value on a Recurring Basis	The following table represents our financial assets and liabilities measured at estimated fair value on a recurring basis: Fair value measurement using Quoted prices Significant prices in other Significant active observable unobservable markets inputs inputs (Level 1) (Level 2) (Level 3) Total June 30, 2021 Assets: Short-term investments $ 1,491,286 $ - $ - $ 1,491,286 Restricted short-term investments 14,336 - - 14,336 Other financial assets 268 - 784,236 784,504 Liabilities: Convertible senior notes - 636,042 - 636,042 Liability arising from Acreage Arrangement - - 450,000 450,000 Warrant derivative liability - - 299,318 299,318 March 31, 2021 Assets: Short-term investments $ 1,144,563 $ - $ - $ 1,144,563 Restricted short-term investments 11,332 - - 11,332 Other financial assets 254 - 700,728 700,982 Liabilities: Convertible senior notes - 687,414 - 687,414 Liability arising from Acreage Arrangement - - 600,000 600,000 Warrant derivative liability - - 615,575 615,575
Level 2
Summary of Valuation Techniques and Significant Unobservable Inputs in the Fair Value Measurement of Significant Level 2 and Level 3 Financial Instruments	The following table summarizes the valuation techniques and significant unobservable inputs in the fair value measurement of significant level 2 financial instruments: Financial asset / financial liability Valuation techniques Key inputs Convertible senior notes Convertible note pricing model Quoted prices in over-the-counter broker market
Level 3
Summary of Valuation Techniques and Significant Unobservable Inputs in the Fair Value Measurement of Significant Level 2 and Level 3 Financial Instruments	The following table summarizes the valuation techniques and significant unobservable inputs in the fair value measurement of significant level 3 financial instruments: Financial asset / financial liability Valuation techniques Significant unobservable inputs Relationship of unobservable inputs to fair value Acreage financial instrument Probability weighted expected return model Probability of each scenario Change in probability of occurrence in each scenario will result in a change in fair value Number of common shares to be issued Increase or decrease in value and number of common shares will result in a decrease or increase in fair value Probability and timing of US legalization Increase or decrease in probability of US legalization will result in an increase or decrease in fair value Estimated premium on US legalization Increase or decrease in estimated premium on US legalization will result in an increase or decrease in fair value Control premium Increase or decrease in estimated control premium will result in an increase or decrease in fair value Market access premium Increase or decrease in estimated market access premium will result in an increase or decrease in fair value TerrAscend Exchangeable Shares, TerrAscend Option Put option pricing model Probability and timing of US legalization Increase or decrease in probability of US legalization will result in an increase or decrease in fair value Hempco Debenture Discounted cash flow Discount rate Increase or decrease in discount rate will result in a decrease or increase in fair value TerrAscend warrants - October 2019, March 2020, December 2020 Monte Carlo simulation model Probability and timing of US legalization Increase or decrease in probability of US legalization will result in an increase or decrease in fair value Arise Bioscience term loan, TerrAscend Canada term loan - Discounted cash flow Probability and timing of US legalization Increase or decrease in probability of US legalization will result in an increase or decrease in fair value October 2019, March 2020 Discount rate Increase or decrease in discount rate will result in a decrease or increase in fair value SLANG Worldwide Warrant Black-Sholes option pricing model Probability and timing of US legalization Increase or decrease in probability of US legalization will result in an increase or decrease in fair value Warrant derivative liability Monte Carlo simulation model Volatility of Canopy Growth share price Increase or decrease in volatility will result in an increase or decrease in fair value BioSteel redeemable NCI Discounted cash flow Discount rate Increase or decrease in discount rate will result in a decrease or increase in fair value Future wholesale price and production levels Increase or decrease in future wholesale price and production levels will result in an increase or decrease in fair value Vert Mirabel redeemable noncontrolling interest Discounted cash flow Discount rate Increase or decrease in discount rate will result in a decrease or increase in fair value Future wholesale price and production levels Increase or decrease in future wholesale price and production levels will result in an increase or decrease in fair value

Revenue (Tables)

Revenue (Tables)	3 Months Ended
	Jun. 30, 2021
Revenue From Contract With Customer [Abstract]
Summary of Disaggregation of Revenue	Revenue is dissaggregated as follows: Three months ended June 30, June 30, 2021 2020 Canadian recreational cannabis net revenue Business-to-business 1 $ 42,693 $ 34,934 Business-to-consumer 17,344 9,330 60,037 44,264 Canadian medical cannabis net revenue 2 13,492 13,910 73,529 58,174 International and other revenue C 3 11,443 15,369 Other 7,967 5,739 19,410 21,108 Global cannabis net revenue 92,939 79,282 Other consumer products Storz & Bickel 24,070 17,120 This Works 6,551 6,049 BioSteel 6,661 2,448 Other 5,988 5,517 Other consumer products revenue 43,270 31,134 Net revenue $ 136,209 $ 110,416

Other Income (Expense), Net (Ta

Other Income (Expense), Net (Tables)	3 Months Ended
	Jun. 30, 2021
Other Income And Expenses [Abstract]
Schedule of Other Income (Expense), Net	Other income (expense), net is dissaggregated as follows: Three months ended June 30, June 30, 2021 2020 Fair value changes on other financial assets $ 84,152 $ 21,807 Fair value changes on liability arising from Acreage Arrangement 150,000 (35,000 ) Fair value changes on convertible senior notes 50,712 (20,334 ) Fair value change on warrant derivative liability 316,257 35,369 Fair value changes on acquisition related contingent consideration (199 ) 39,983 Interest income 2,647 8,993 Interest expense (24,564 ) (1,155 ) Foreign currency loss 1,030 (5,959 ) Loss on disposal of consolidated entity (2,339 ) - Other income (expense), net 2,970 4,501 $ 580,666 $ 48,205

Acquisitions (Tables)

Acquisitions (Tables)	3 Months Ended
	Jun. 30, 2021
Business Combinations [Abstract]
Summary of Consolidated Balance Sheet Impact at Acquisition of Company's Business Combinations	The following table summarizes the consolidated balance sheet impact at acquisition of the Company’s business combinations that occurred in the three months ended June 30, 2021: Ace Supreme Valley Cannabis (i) (ii) Total Cash and cash equivalents $ 1,544 $ 41,306 $ 42,850 Inventory 878 33,681 34,559 Other current assets 2,249 15,145 17,394 Property, plant and equipment 105 179,123 179,228 Intangible assets Brands 14,000 20,900 34,900 Distribution channel - 3,000 3,000 Operating licenses - 10,500 10,500 Goodwill 36,464 85,910 122,374 Accounts payable and other accrued expenses and liabilities (1,148 ) (13,258 ) (14,406 ) Debt and other liabilities - (90,482 ) (90,482 ) Deferred income tax liabilities - (6,157 ) (6,157 ) Net assets acquired $ 54,092 $ 279,668 $ 333,760 Consideration paid in cash $ 51,623 $ 84 $ 51,707 Consideration paid in shares - 260,668 260,668 Replacement options - 629 629 Replacement warrants - 13,350 13,350 Other consideration 2,469 4,937 7,406 Total consideration $ 54,092 $ 279,668 $ 333,760 Consideration paid in cash $ 51,623 $ 84 $ 51,707 Less: Cash and cash equivalents acquired (1,544 ) (41,306 ) (42,850 ) Net cash outflow (inflow) $ 50,079 $ (41,222 ) $ 8,857

Segment Information (Tables)

Segment Information (Tables)	3 Months Ended
	Jun. 30, 2021
Segment Reporting [Abstract]
Summary of Reconciliation of Operating Profit (Loss) from Segments to Consolidated	The Company’s global cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Company’s other consumer products segment comprises the production, distribution and sale of consumer products, including (i) Storz & Bickel vaporizers; (ii) This Works beauty, skincare, wellness and sleep products; (iii) BioSteel sports nutrition beverages, mixes, protein, gum and mints; and (iv) other revenue sources. The Company’s CODM evaluates the performance of these two segments focusing on (i) segment net revenue, and (ii) segment gross margin and gross margin percentage as the measure of segment profit or loss. Accordingly, information regarding segment net revenue and segment gross margin for the comparative periods has been recast to reflect the aforementioned change in reportable segments. Three months ended June 30, June 30, 2021 2020 Segmented net revenue Global cannabis $ 92,939 $ 79,282 Other consumer products 43,270 31,134 $ 136,209 $ 110,416 Segmented gross margin: Global cannabis $ 13,369 $ (6,858 ) Other consumer products 13,869 13,353 27,238 6,495 Selling, general and administrative expenses 112,574 135,392 Share-based compensation 13,126 30,685 Asset impairment and restructuring costs 89,249 12,794 Operating loss (187,711 ) (172,376 ) Loss from equity method investments (100 ) (7,189 ) Other income (expense), net 580,666 48,205 Net income (loss) before incomes taxes $ 392,855 $ (131,360 )
Summary of Disaggregation of Net Revenue by Geographic Area	Disaggregation of net revenue by geographic area: Three months ended June 30, June 30, 2021 2020 Canada $ 82,612 $ 65,717 Germany 26,106 27,997 United States 19,867 10,445 Other 7,624 6,257 $ 136,209 $ 110,416
Summary of Disaggregation of Long-lived Assets by Geographic Areas	Disaggregation of property, plant and equipment by geographic area: June 30, March 31, 2021 2021 Canada $ 931,042 $ 847,678 United States 143,283 143,747 Other 68,289 83,112 $ 1,142,614 $ 1,074,537

Asset Impairment and Restruct_2

Asset Impairment and Restructuring Costs - Additional Information (Details) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Restructuring And Related Activities [Abstract]
Asset impairment and restructuring costs	$ 89,249	$ 12,794

Cash and Cash Equivalents - Com

Cash and Cash Equivalents - Components of Cash and Cash Equivalents (Details) - CAD ($) $ in Thousands	Jun. 30, 2021	Mar. 31, 2021
Cash And Cash Equivalents [Abstract]
Cash	$ 367,284	$ 436,588
Cash equivalents	192,556	718,065
Cash And Cash Equivalents At Carrying Value	$ 559,840	$ 1,154,653

Short-term Investments - Compon

Short-term Investments - Components of Short-term Investments (Details) - CAD ($) $ in Thousands	Jun. 30, 2021	Mar. 31, 2021
Marketable Securities [Line Items]
Short-term investments	$ 1,491,286	$ 1,144,563
Term Deposits
Marketable Securities [Line Items]
Short-term investments	442,916	463,824
Government securities
Marketable Securities [Line Items]
Short-term investments	92,360	136,620
Asset-backed Securities
Marketable Securities [Line Items]
Short-term investments	252,848	16,342
Commercial paper and other
Marketable Securities [Line Items]
Short-term investments	$ 703,162	$ 527,777

Short-term Investments - Additi

Short-term Investments - Additional Information (Details) - CAD ($) $ in Thousands	Jun. 30, 2021	Mar. 31, 2021
Short Term Investments [Abstract]
Amortized cost of short-term investments	$ 1,492,227	$ 1,145,364

Amounts Receivable, Net - Compo

Amounts Receivable, Net - Components of Amounts Receivable, Net (Details) - CAD ($) $ in Thousands	Jun. 30, 2021	Mar. 31, 2021
Receivables [Abstract]
Accounts receivable, net	$ 87,582	$ 67,106
Indirect taxes receivable	8,674	8,281
Interest receivable	6,052	5,140
Other receivables	4,147	11,908
Amounts receivable, net	$ 106,455	$ 92,435

Amounts Receivable, Net - Addit

Amounts Receivable, Net - Additional Information (Details) - CAD ($) $ in Thousands	Jun. 30, 2021	Mar. 31, 2021
Receivables [Abstract]
Allowance for doubtful accounts	$ 1,582	$ 1,411

Inventory - Components of Inven

Inventory - Components of Inventory (Details) - CAD ($) $ in Thousands	Jun. 30, 2021	Mar. 31, 2021
Inventory Disclosure [Abstract]
Raw materials, packaging supplies and consumables	$ 66,006	$ 55,554
Work in progress	219,816	223,652
Finished goods	125,853	88,773
Inventory	$ 411,675	$ 367,979

Inventory - Additional Informat

Inventory - Additional Information (Details) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Inventory Disclosure [Abstract]
Inventory write-downs	$ 6,014	$ 19,386

Prepaid Expenses and Other As_3

Prepaid Expenses and Other Assets - Components of Prepaid and Other Assets (Details) - CAD ($) $ in Thousands	Jun. 30, 2021	Mar. 31, 2021
Prepaid Expense And Other Assets Current [Abstract]
Prepaid expenses	$ 44,412	$ 28,349
Deposits	21,008	18,316
Prepaid inventory	1,157	1,496
Other assets	25,007	19,071
Prepaid and other assets	$ 91,584	$ 67,232

Other Financial Assets - Summar

Other Financial Assets - Summary of Changes in Other Financial Assets (Details) $ in Thousands	3 Months Ended
	Jun. 30, 2021CAD ($)
Schedule Of Investments [Line Items]
Beginning balance	$ 708,167
Fair value changes	84,152
Foreign currency translation adjustments	(530)
Exercise of options / disposal of shares	(131)
Ending balance	791,658
TerrAscend Exchangeable Shares | Exchangeable Shares
Schedule Of Investments [Line Items]
Beginning balance	385,000
Fair value changes	53,000
Ending balance	438,000
TerrAscend Canada - October 2019 | Warrants
Schedule Of Investments [Line Items]
Beginning balance	17,250
Fair value changes	2,780
Ending balance	20,030
TerrAscend Canada - October 2019 | Term loan / debenture
Schedule Of Investments [Line Items]
Beginning balance	10,240
Fair value changes	540
Ending balance	10,780
TerrAscend - March 2020 | Warrants
Schedule Of Investments [Line Items]
Beginning balance	152,910
Fair value changes	22,820
Ending balance	175,730
Arise Bioscience | Term loan / debenture
Schedule Of Investments [Line Items]
Beginning balance	56,330
Fair value changes	3,350
Ending balance	59,680
TerrAscend - December 2020 | Warrants
Schedule Of Investments [Line Items]
Beginning balance	13,240
Fair value changes	1,840
Ending balance	15,080
Acreage Hempco1 | Debenture
Schedule Of Investments [Line Items]
Beginning balance	27,448	[1]
Fair value changes	1,302	[1]
Foreign currency translation adjustments	(359)	[1]
Ending balance	28,391	[1]
Arise Bioscience | Term loan / debenture
Schedule Of Investments [Line Items]
Beginning balance	13,077
Fair value changes	1,376
Foreign currency translation adjustments	(171)
Ending balance	14,282
TerrAscend | Equity Option
Schedule Of Investments [Line Items]
Beginning balance	10,600
Fair value changes	1,500
Ending balance	12,100
Other At Fair Value Through Net Income Loss | Various
Schedule Of Investments [Line Items]
Beginning balance	5,487
Fair value changes	(356)
Exercise of options / disposal of shares	(100)
Ending balance	5,031
Slang Worldwide Inc | Warrants
Schedule Of Investments [Line Items]
Beginning balance	9,400
Fair value changes	(4,000)
Ending balance	5,400
Other - Classified as Held for Investment | Loan Receivable
Schedule Of Investments [Line Items]
Beginning balance	7,185
Exercise of options / disposal of shares	(31)
Ending balance	$ 7,154
[1]	See Note 27 for information regarding Acreage Hempco

Property, Plant and Equipment -

Property, Plant and Equipment - Schedule of Components of Property, Plant and Equipment (Details) - CAD ($) $ in Thousands	Jun. 30, 2021	Mar. 31, 2021
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	$ 1,363,903	$ 1,297,127
Less: Accumulated depreciation	(221,289)	(222,590)
Property, plant and equipment, net	1,142,614	1,074,537
Buildings and Greenhouses
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	833,426	651,166
Buildings and Greenhouses | Right-of-Use-Assets
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	100,530	100,517
Production and Warehouse Equipment
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	210,671	216,925
Production and Warehouse Equipment | Right-of-Use-Assets
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	530	530
Leasehold Improvements
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	101,163	106,837
Land
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	33,158	34,747
Office and Lab Equipment
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	35,053	30,546
Computer Equipment
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	22,719	26,431
Assets in Process
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	$ 26,653	$ 129,428

Property, Plant and Equipment_2

Property, Plant and Equipment - Additional Information (Details) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Property Plant And Equipment [Line Items]
Depreciation of property, plant and equipment	$ 17,116	$ 17,415
Cost of Goods Sold
Property Plant And Equipment [Line Items]
Depreciation of property, plant and equipment	10,462	14,786
Selling, General and Administrative Expenses
Property Plant And Equipment [Line Items]
Depreciation of property, plant and equipment	$ 6,654	$ 2,629

Intangible Assets - Summary of

Intangible Assets - Summary of Components of Intangible Assets (Details) - CAD ($) $ in Thousands	Jun. 30, 2021	Mar. 31, 2021
Intangible Assets Net Excluding Goodwill [Line Items]
Gross Carrying Amount	$ 349,800	$ 337,456
Net Carrying Amount	237,094	232,826
Total intangible assets	347,063	308,167
Intellectual Property
Intangible Assets Net Excluding Goodwill [Line Items]
Gross Carrying Amount	211,069	212,100
Net Carrying Amount	165,077	168,655
Distribution Channel
Intangible Assets Net Excluding Goodwill [Line Items]
Gross Carrying Amount	76,599	73,756
Net Carrying Amount	35,208	35,176
Software and Domain Names
Intangible Assets Net Excluding Goodwill [Line Items]
Gross Carrying Amount	29,655	27,836
Net Carrying Amount	18,193	18,149
Brands
Intangible Assets Net Excluding Goodwill [Line Items]
Gross Carrying Amount	21,102	21,812
Net Carrying Amount	7,241	8,894
Operating Licenses
Intangible Assets Net Excluding Goodwill [Line Items]
Gross Carrying Amount	10,500	0
Net Carrying Amount	10,500	0
Indefinite lived intangible assets	8,000	8,000
Amortizable Intangibles in Process
Intangible Assets Net Excluding Goodwill [Line Items]
Gross Carrying Amount	875	1,952
Net Carrying Amount	875	1,952
Acquired Brands
Intangible Assets Net Excluding Goodwill [Line Items]
Indefinite lived intangible assets	$ 101,969	$ 67,341

Intangible Assets - Additional

Intangible Assets - Additional Information (Details) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Finite Lived Intangible Assets [Line Items]
Amortization of intangible assets	$ 8,016	$ 16,632
Cost of Goods Sold
Finite Lived Intangible Assets [Line Items]
Amortization of intangible assets	18	702
Selling, General and Administrative Expenses
Finite Lived Intangible Assets [Line Items]
Amortization of intangible assets	$ 7,998	$ 15,930

Goodwill - Changes in Carrying

Goodwill - Changes in Carrying Amount of Goodwill (Details) - CAD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Jun. 30, 2021	Mar. 31, 2021
Goodwill [Line Items]
Beginning Balance	$ 1,889,354	$ 1,954,471
Purchase accounting allocations	122,374
Foreign currency translation adjustments	(6,025)	(65,117)
Ending Balance	2,000,458	$ 1,889,354
Consolidated Entities
Goodwill [Line Items]
Disposal of consolidated entities	$ (5,245)

Other Accrued Expenses and Li_3

Other Accrued Expenses and Liabilities - Components of Other Accrued Expenses and Liabilities (Details) - CAD ($) $ in Thousands	Jun. 30, 2021	Mar. 31, 2021
Accounts Payable And Accrued Liabilities Current [Abstract]
Employee compensation	$ 36,061	$ 47,237
Taxes and government fees	14,250	13,550
Professional fees	7,303	11,544
Other	22,324	28,482
Other accrued expenses and liabilities	$ 79,938	$ 100,813

Debt - Summary of Components of

Debt - Summary of Components of Debt (Details) - CAD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Mar. 18, 2021
Debt Instrument [Line Items]
Principal amount			$ 750,000
Other revolving debt facility, loan, and financings	$ 3,475	$ 3,872
Long Term Debt	1,560,778	1,582,963
Current portion of long-term debt	15,705	9,827
Long-term debt	1,545,073	1,573,136
Debt	1,560,778	1,582,963
Less: current portion	(15,705)	(9,827)
Long-term portion	$ 1,545,073	1,573,136
4.25% Convertible Senior Notes [Member]
Debt Instrument [Line Items]
Convertible senior notes at 4.25%, Maturity Date	Jul. 15, 2023
Principal amount	$ 600,000	600,000
Accrued interest	12,042	5,664
Non-credit risk fair value adjustment	52,620	109,710
Credit risk fair value adjustment	(28,620)	(27,960)
Senior Notes	$ 636,042	687,414
Convertible Debentures
Debt Instrument [Line Items]
Convertible debentures	Sep. 10, 2025
Convertible debentures	$ 30,532
Accretion Debentures
Debt Instrument [Line Items]
Convertible debentures	Sep. 10, 2025
Accretion debentures	$ 9,802
Revolving Credit Facility
Debt Instrument [Line Items]
Convertible debentures	Mar. 18, 2026
Credit facility	$ 880,927	$ 891,677

Debt - Summary of Components _2

Debt - Summary of Components of Debt (Parenthetical) (Details)	Dec. 31, 2020
4.25% Convertible Senior Notes [Member]
Debt Instrument [Line Items]
Annual interest rate	4.25%

Debt - Additional Information (

Debt - Additional Information (Details)	Mar. 18, 2021CAD ($)	Aug. 13, 2019CAD ($)	Jun. 20, 2018CAD ($)Trading_Day$ / shares	Sep. 09, 2020CAD ($)$ / shares	Oct. 19, 2018CAD ($)	Jun. 30, 2021CAD ($)	Jun. 30, 2020CAD ($)
Debt Instrument [Line Items]
Principal amount	$ 750,000,000
Proceeds from the Credit Facility	893,160,000
Accretion Rate				11.06%
Conversion Of Outstanding Debentures Description				In addition, the Company may force conversion of the Supreme Debentures outstanding with 30 days’ notice if the daily volume weighted average trading price of the Company’s common shares is greater than $38.59 for any 10 consecutive trading days.
Supreme Cannabis [Member]
Debt Instrument [Line Items]
Interest at a rate				1.00%	6.00%
Annual interest rate				1.00%	6.00%
Proceeds from the Credit Facility					$ 100,000,000
Maturity date				Sep. 10, 2025
Conversion price | $ / shares				$ 0.285
Cancellation of Debt				$ 63,500,000
Convertible senior notes at 4.25%, Maturity Date				Sep. 10, 2025
Farm Credit Canada | Tweed Farms Inc | Revolving Credit Facility
Debt Instrument [Line Items]
Interest at a rate						3.45%
Annual interest rate						3.45%
Line of credit facility, maximum borrowing capacity		$ 40,000,000
Extinguishment of debt, amount		$ 4,912,000
Debt instrument, description of variable rate basis						prime rate plus 1.0%
Debt Instrument, Basis Spread on Variable Rate						1.00%
Minimum
Debt Instrument [Line Items]
Liquidity requirement	200,000,000
Minimum | Supreme Cannabis [Member]
Debt Instrument [Line Items]
Proceeds from the Credit Facility				$ 13,500,000
Maximum [Member] | Supreme Cannabis [Member]
Debt Instrument [Line Items]
Interest at a rate				8.00%
Annual interest rate				8.00%
Proceeds from the Credit Facility				$ 36,500,000
Credit Facility
Debt Instrument [Line Items]
Senior credit facility	$ 500,000
4.25% Convertible Senior Notes [Member]
Debt Instrument [Line Items]
Interest at a rate	8.50%
Annual interest rate	8.50%
L I B O R Floor
Debt Instrument [Line Items]
Interest at a rate	1.00%
Annual interest rate	1.00%
4.25% Convertible Senior Notes [Member]
Debt Instrument [Line Items]
Principal amount			$ 600,000,000
Interest at a rate			4.25%
Annual interest rate			4.25%
Frequency of periodic payment team			semi-annually on January 15th and July 15th of each year commencing from January 15, 2019
Maturity date			Jul. 15, 2023
Convertible senior notes conversion time start from			Jan. 15, 2023
Conversion rate for every dollar one of principal amount of notes | $ / shares			$ 20.7577
Convertible, If-converted value in excess of principal			$ 1,000
Conversion price | $ / shares			$ 48.18
Debt Conversion, Description			(i) the market price of the Company common shares for at least 20 trading days during a period of 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day, (ii) during the 5 business day period after any consecutive 5 trading day period (the “measurement period”) in which the trading price per $1 principal amount of the Notes for each trading day in the measurement period was less than 98% of the product of the last reported sales price of the Company’s common shares and the conversion rate on each such trading day, (iii) the Notes are called for redemption or (iv) upon occurrence of certain corporate events (“Fundamental Change”). A Fundamental Change occurred upon completion of the investment by Constellation Brands, Inc. (“CBI”) in the Company in November 2018, and no holders of Notes surrendered any portion of their Notes in connection therewith
Conversion price percentage			130.00%			130.00%
Convertible measurement period threshold trading days			5 days
Convertible measurement period threshold consecutive trading days			5 days
Convertible conversion price | $ / shares			$ 1
Maximum discount to last reported sales price			98.00%
Debt instrument, redemption, description						The Company cannot redeem the Notes prior to July 20, 2021, except in the event of certain changes in Canadian tax law.
Debt instrument, redemption period, start date						Jul. 20, 2021
Debt instrument, redemption threshold trading days						20 days
Debt instrument, redemption threshold consecutive trading days						30 days
Number of trading days to provide notice of redemption						5 days
Debt instrument, redemption price, percentage						100.00%
Debt instrument, change in fair value of notes						$ 51,372,000	$ 35,694,000
Debt instrument, change in fair value of notes from contractual interest						$ 6,378,000	$ 6,444,000
Convertible senior notes at 4.25%, Maturity Date			Jul. 15, 2023
4.25% Convertible Senior Notes [Member] | Minimum
Debt Instrument [Line Items]
Threshold consecutive trading days | Trading_Day			20
4.25% Convertible Senior Notes [Member] | Maximum [Member]
Debt Instrument [Line Items]
Threshold consecutive trading days | Trading_Day			30

Other Liabilities - Components

Other Liabilities - Components of Other Liabilities (Details) - CAD ($) $ in Thousands	Jun. 30, 2021	Mar. 31, 2021
Other Liabilities Current [Abstract]
Lease liabilities	$ 36,862	$ 42,061
Acquisition consideration related liabilities	10,095	16,577
Refund liability	8,387	6,441
Settlement liabilities and other	13,804	41,349
Other Liabilities Current	69,148	106,428
Long-term
Lease liabilities, long-term	93,174	94,164
Acquisition consideration related liabilities, long-term	10,393	7,808
Settlement liabilities and other	5,471	5,268
Other liabilities, long-term	109,038	107,240
Total
Lease liabilities	130,036	136,225
Acquisition consideration related liabilities	20,488	24,385
Refund liability	8,387	6,441
Settlement liabilities and other	19,275	46,617
Other liabilities	$ 178,186	$ 213,668

Redeemable Noncontrolling Int_3

Redeemable Noncontrolling Interest - Summary of Net Change in Redeemable Noncontrolling Interests (Details) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Redeemable Noncontrolling Interest [Line Items]
Beginning balance	$ 135,300	$ 69,750
Net income (loss) attributable to redeemable noncontrolling interest	(2,463)	(10,663)
Adjustments to redemption amount	2,463	22,513
Ending balance	135,300	81,600
Vert Mirabel
Redeemable Noncontrolling Interest [Line Items]
Beginning balance	11,500	20,250
Net income (loss) attributable to redeemable noncontrolling interest	1,293	(9,253)
Adjustments to redemption amount	(1,293)	18,803
Ending balance	11,500	29,800
Bio Steel
Redeemable Noncontrolling Interest [Line Items]
Beginning balance	123,800	49,500
Net income (loss) attributable to redeemable noncontrolling interest	(3,756)	(1,410)
Adjustments to redemption amount	3,756	3,710
Ending balance	$ 123,800	$ 51,800

Share Capital - Additional Info

Share Capital - Additional Information (Details)	Jun. 30, 2021	Jun. 30, 2020
Equity [Abstract]
Number of equity financings	0	0

Share Capital - Summary of Issu

Share Capital - Summary of Issuances of Stock Other (Details) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Equity Class Of Treasury Stock [Line Items]
Number of shares	9,888,801	1,164,339
Completion of acquisition milestones, Number of shares	875,401	751,922
Share capital	$ 285,915	$ 26,214
Share based reserve	(25,692)	(26,798)
Share Capital
Equity Class Of Treasury Stock [Line Items]
Completion of acquisition milestones	25,247	12,079
Share-based Reserve
Equity Class Of Treasury Stock [Line Items]
Completion of acquisition milestones	$ (25,692)	$ (12,079)
Acquisition Of Supreme Cannabis [Member]
Equity Class Of Treasury Stock [Line Items]
Number of shares	9,013,400
Share capital	$ 260,668
Other Issuances
Equity Class Of Treasury Stock [Line Items]
Number of shares		412,417
Share capital		$ 14,135
Share based reserve		$ (14,719)

Share Capital - Summary of Warr

Share Capital - Summary of Warrants (Details) - CAD ($)	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Warrants And Rights Note Disclosure [Abstract]
Number of whole warrants, Beginning balance	127,073,136	146,299,443
Number of whole warrants,Supreme Cannabis Warrants	1,265,742
Number of whole warrants, Expiry of warrants	(145,831)
Number of whole warrants, Ending balance	128,193,047	127,422,542
Average exercise price, Beginning balance	$ 58.33	$ 52.44
Average exercise price,Supreme Cannabis warrants	25.61
Average exercise price, Expiry of warrants	$ 32.61
Average exercise price, Ending balance	$ 58.04	$ 58.29
Warrant value, Beginning balance	$ 2,568,438,000	$ 2,638,951,000
Warrant Value, Supreme Cannabis warrants	13,350,000
Warrant value, Expiry of warrants
Warrant value, Ending balance	$ 2,581,788,000	$ 2,568,685,000
Number of whole warrants, Exercise of warrants		(18,876,901)
Average exercise price, Exercise of warrants		$ 12.98
Average exercise price, Exercise of warrants		$ (70,266,000)

Share-Based Compensation - Addi

Share-Based Compensation - Additional Information (Details) - CAD ($) $ / shares in Units, $ in Thousands	May 27, 2021	Sep. 21, 2020	Jun. 30, 2021	Jun. 30, 2020	Mar. 31, 2021	Jun. 22, 2021	Mar. 31, 2020	Oct. 01, 2019
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options extended period		10 years
Options maximum period		6 years
Weighted average exercise price of options outstanding			$ 36.50		$ 36.79
Weighted average exercise price of options exercisable			$ 37.23		$ 36.97
Proceeds from exercise of stock options			$ 3,592	$ 4,722
Number of common shares released on completion of acquisition milestones			9,888,801	751,922
Number of shares to be issued on completion of acquisition and asset purchase milestones			645,509
Stock options outstanding			17,389,260
Share-based compensation			$ 13,126	$ 30,685
Canopy Rivers Corporation
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation expense				1,301
Bio Steel Sports Nutrition Inc
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of outstanding shares purchased								72.00%
Stock options outstanding			1,549,800				1,581,000
Vesting period			5 years
Share-based compensation			$ 265	244	$ 244
Supreme Cannabis [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation expense			823
Percentage of outstanding shares purchased						100.00%
Employee Stock Option
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation expense			$ 8,044	$ 22,328
Stock Option Subject To Performance Conditions
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation expense, options subject to performance conditions			1,559,413	2,060,068
RSUs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation expense			$ 2,295	$ 3,842
Omnibus Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of common shares reserved for Awards			39,311,910
Options expiration period		10 years
Weighted average exercise price of options outstanding			$ 36.50		$ 36.79
Options exercised			205,335	711,472
Exercise price			$ 17.50
Proceeds from exercise of stock options			$ 3,592	$ 4,722
Stock options outstanding			17,389,260		17,704,311
Omnibus Incentive Plan | Share-based Payment Arrangement, Tranche One
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of options exercisable on each anniversaries from date of grant		33.33%
Omnibus Incentive Plan | Share-based Payment Arrangement, Tranche Two
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of options exercisable on each anniversaries from date of grant		33.33%
Omnibus Incentive Plan | Share-based Payment Arrangement, Tranche Three
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of options exercisable on each anniversaries from date of grant		33.33%
Employee Stock Purchase Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Aggregate number of common shares authorized			600,000
Equity shares issued to shareholders			0
Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of number of shares issuable from treasury pursuant to awards	15.00%
Maximum [Member] | Omnibus Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Exercise price			$ 36.34	$ 27.99
Maximum [Member] | Employee Stock Purchase Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Equity shares issued to shareholders			300,000
Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of number of shares issuable from treasury pursuant to awards	10.00%
Minimum | Omnibus Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Exercise price			$ 2.68	$ 1.32

Share-Based Compensation - Summ

Share-Based Compensation - Summary of the Changes in Options Outstanding Under the Omnibus Plan (Details) - shares	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options outstanding, ending balance	17,389,260
Omnibus Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options outstanding, beginning balance	17,704,311
Options granted	560,085
Replacement options issued as a result of the acquisition of Supreme Cannabis	140,159
Options exercised	(205,335)	(711,472)
Options forfeited	(809,960)
Options outstanding, ending balance	17,389,260

Share-Based Compensation - Su_2

Share-Based Compensation - Summary of the Changes in Omnibus Plan Employee Options (Details)	3 Months Ended
	Jun. 30, 2021$ / shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Weighted average exercise price outstanding, beginning balance	$ 36.79
Weighted average exercise price outstanding, ending balance	36.50
Omnibus Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Weighted average exercise price outstanding, beginning balance	36.79
Weighted average exercise price, Options granted	30.87
Replacement options issued as a result of the acquisition of Supreme Cannabis	80.53
Weighted average exercise price, Options exercised	17.50
Weighted average exercise price, Options forfeited	43.79
Weighted average exercise price outstanding, ending balance	$ 36.50

Share-Based Compensation - Su_3

Share-Based Compensation - Summary of Outstanding Stock Options (Details)	3 Months Ended
	Jun. 30, 2021$ / sharesshares
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Options Outstanding	17,389,260
Options Outstanding, Weighted Average Remaining Contractual Life	3 years 7 months 24 days
Options Exercisable	10,188,191
Options Exercisable, Weighted Average Remaining Contractual Life	3 years 3 months
Range One
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Range of Exercise Prices, Lower Range | $ / shares	$ 0.06
Range of Exercise Prices, Upper Range | $ / shares	$ 24.62
Options Outstanding	2,357,356
Options Outstanding, Weighted Average Remaining Contractual Life	3 years 1 month 24 days
Options Exercisable	1,407,826
Options Exercisable, Weighted Average Remaining Contractual Life	2 years 5 months 4 days
Range Two
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Range of Exercise Prices, Lower Range | $ / shares	$ 24.63
Range of Exercise Prices, Upper Range | $ / shares	$ 33.53
Options Outstanding	4,491,920
Options Outstanding, Weighted Average Remaining Contractual Life	4 years 1 month 9 days
Options Exercisable	2,090,648
Options Exercisable, Weighted Average Remaining Contractual Life	3 years 4 months 9 days
Range Three
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Range of Exercise Prices, Lower Range | $ / shares	$ 33.54
Range of Exercise Prices, Upper Range | $ / shares	$ 36.80
Options Outstanding	3,405,640
Options Outstanding, Weighted Average Remaining Contractual Life	3 years 5 months 1 day
Options Exercisable	2,186,429
Options Exercisable, Weighted Average Remaining Contractual Life	3 years 5 months 1 day
Range Four
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Range of Exercise Prices, Lower Range | $ / shares	$ 36.81
Range of Exercise Prices, Upper Range | $ / shares	$ 42.84
Options Outstanding	2,992,796
Options Outstanding, Weighted Average Remaining Contractual Life	3 years 8 months 4 days
Options Exercisable	2,034,251
Options Exercisable, Weighted Average Remaining Contractual Life	3 years 2 months 19 days
Range Five
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Range of Exercise Prices, Lower Range | $ / shares	$ 42.85
Range of Exercise Prices, Upper Range | $ / shares	$ 171.54
Options Outstanding	4,141,548
Options Outstanding, Weighted Average Remaining Contractual Life	3 years 7 months 20 days
Options Exercisable	2,469,037
Options Exercisable, Weighted Average Remaining Contractual Life	3 years 6 months 21 days

Share-Based Compensation - Su_4

Share-Based Compensation - Summary of Assumptions Applied to Establish Fair Value of Options Granted Using Black-Scholes Option Pricing Model (Details) - $ / shares	3 Months Ended	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Risk-free interest rate	0.67%	0.33%
Expected volatility	76.00%	76.00%
Expected forfeiture rate	18.00%	16.00%
Black-Scholes value of each option	$ 17.25	$ 12.31
Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected life of options (years)	3 years	3 years
Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected life of options (years)	5 years	5 years

Share-Based Compensation - Su_5

Share-Based Compensation - Summary of the Changes in RSUs (Details) - RSUs	3 Months Ended
	Jun. 30, 2021shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Beginning balance	753,310
RSUs granted	536,314
RSUs released	(149,785)
RSUs cancelled and forfeited	(24,334)
Ending balance	1,115,505

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Loss) - Accumulated Other Comprehensive Income (Details) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance	$ 3,486,520	$ 5,108,120
Other comprehensive income (loss)	(27,278)	(68,484)
Ending balance	4,145,054	5,180,541
Foreign Currency Translation Adjustments
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance	(28,246)	126,723
Other comprehensive income (loss)	(27,938)	(53,124)
Ending balance	(56,184)	73,599
Changes of Own Credit Risk of Financial Liabilities
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance	(5,994)	94,176
Other comprehensive income (loss)	660	(15,360)
Ending balance	(5,334)	78,816
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance	(34,240)	220,899
Ending balance	$ (61,518)	$ 152,415

Noncontrolling Interests - Summ

Noncontrolling Interests - Summary of Net Change in Noncontrolling Interests (Details) - CAD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Mar. 31, 2021
Minority Interest [Line Items]
Beginning balance	$ 3,486,520	$ 5,108,120	$ 5,108,120
Comprehensive income (loss)	(2,463)	(19,821)
Net (income) loss attributable to redeemable noncontrolling interest	2,463	10,663
Share-based compensation	13,126	30,685
Ending balance	4,145,054	5,180,541	3,486,520
Noncontrolling Interests
Minority Interest [Line Items]
Beginning balance	4,709	221,758	221,758
Comprehensive income (loss)	(2,463)	(19,821)
Net (income) loss attributable to redeemable noncontrolling interest	2,463	10,663
Share-based compensation	265	1,545
Ownership changes		852
Warrants		250
Ending balance	4,974	215,247	4,709
Vert Mirabel
Minority Interest [Line Items]
Beginning balance		7,132	7,132
Comprehensive income (loss)	1,293	(14,528)
Net (income) loss attributable to redeemable noncontrolling interest	(1,293)	9,253
Ending balance		1,857
Bio Steel
Minority Interest [Line Items]
Beginning balance	1,658	489	489
Comprehensive income (loss)	(3,756)	(1,410)
Net (income) loss attributable to redeemable noncontrolling interest	3,756	1,410
Share-based compensation	265	244
Ending balance	1,923	733	1,658
Other Non Material Interests
Minority Interest [Line Items]
Beginning balance	3,051	3,051	3,051
Ending balance	$ 3,051	3,051	3,051
Canopy Rivers [Member]
Minority Interest [Line Items]
Beginning balance		211,086	$ 211,086
Comprehensive income (loss)		(3,883)
Share-based compensation		1,301
Ownership changes		852
Warrants		250
Ending balance		$ 209,606

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Summary of Financial Assets and Liabilities Measured at Estimated Fair Value on a Recurring Basis (Details) - Fair Value Measurements Recurring - CAD ($) $ in Thousands	Jun. 30, 2021	Mar. 31, 2021
Assets:
Short-term investments	$ 1,491,286	$ 1,144,563
Restricted short-term investments	14,336	11,332
Other financial assets	784,504	700,982
Liabilities:
Convertible senior notes	636,042	687,414
Acreage
Liabilities:
Derivative liability	450,000	600,000
Warrant
Liabilities:
Derivative liability	299,318	615,575
Level 1
Assets:
Short-term investments	1,491,286	1,144,563
Restricted short-term investments	14,336	11,332
Other financial assets	268	254
Level 2
Liabilities:
Convertible senior notes	636,042	687,414
Level 3
Assets:
Other financial assets	784,236	700,728
Level 3 | Acreage
Liabilities:
Derivative liability	450,000	600,000
Level 3 | Warrant
Liabilities:
Derivative liability	$ 299,318	$ 615,575

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Summary of Valuation Techniques and Significant Unobservable Inputs in the Fair Value Measurement of Significant Level 2 Financial Instruments (Details) - Level 2 - Convertible Senior Notes	3 Months Ended
	Jun. 30, 2021
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Valuation techniques	Convertible note pricing model
Key inputs	Quoted prices in over-the-counter broker market

Fair Value of Financial Instr_5

Fair Value of Financial Instruments - Summary of Valuation Techniques and Significant Unobservable Inputs in the Fair Value Measurement of Significant Level 3 Financial Instruments (Details) - Level 3	3 Months Ended
	Jun. 30, 2021
Acreage Financial Instrument Probability of Each Scenario
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Valuation techniques	Probability weighted expected return model
Significant unobservable inputs	Probability of each scenario
Relationship of unobservable inputs to fair value	Change in probability of occurrence in each scenario will result in a change in fair value
Acreage Financial Instrument Value and Number of Canopy Shares Issued
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Significant unobservable inputs	Number of common shares to be issued
Relationship of unobservable inputs to fair value	Increase or decrease in value and number of common shares will result in a decrease or increase in fair value
Acreage Financial Instrument Intrinsic Value of Acreage
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Significant unobservable inputs	Probability and timing of US legalization
Relationship of unobservable inputs to fair value	Increase or decrease in probability of US legalization will result in an increase or decrease in fair value
Acreage Financial Instrument Probability and Timing of US Legalization
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Significant unobservable inputs	Estimated premium on US legalization
Relationship of unobservable inputs to fair value	Increase or decrease in estimated premium on US legalization will result in an increase or decrease in fair value
Acreage Financial Instrument Estimated Premium on US Legalization
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Significant unobservable inputs	Control premium
Relationship of unobservable inputs to fair value	Increase or decrease in estimated control premium will result in an increase or decrease in fair value
Acreage Financial Instrument Control Premium
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Significant unobservable inputs	Market access premium
Relationship of unobservable inputs to fair value	Increase or decrease in estimated market access premium will result in an increase or decrease in fair value
TerrAscend Exchangeable Shares, TerrAscend Option
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Valuation techniques	Put option pricing model
Significant unobservable inputs	Probability and timing of US legalization
Relationship of unobservable inputs to fair value	Increase or decrease in probability of US legalization will result in an increase or decrease in fair value
Hempco Debenture
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Valuation techniques	Discounted cash flow
Significant unobservable inputs	Discount rate
Relationship of unobservable inputs to fair value	Increase or decrease in discount rate will result in a decrease or increase in fair value
TerrAscend Warrants - October 2019, March 2020, December 2020
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Valuation techniques	Monte Carlo simulation model
Significant unobservable inputs	Probability and timing of US legalization
Relationship of unobservable inputs to fair value	Increase or decrease in probability of US legalization will result in an increase or decrease in fair value
Arise Bioscience term loan
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Valuation techniques	Discounted cash flow
Significant unobservable inputs	Probability and timing of US legalization
Relationship of unobservable inputs to fair value	Increase or decrease in probability of US legalization will result in an increase or decrease in fair value
TerrAscend Canada Term Loan - October 2019 March 2020
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Significant unobservable inputs	Discount rate
Relationship of unobservable inputs to fair value	Increase or decrease in discount rate will result in a decrease or increase in fair value
SLANG Worldwide Warrant
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Valuation techniques	Black-Sholes option pricing model
Significant unobservable inputs	Probability and timing of US legalization
Relationship of unobservable inputs to fair value	Increase or decrease in probability of US legalization will result in an increase or decrease in fair value
Warrant Derivative Liability Volatility of Canopy Growth Share Price
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Valuation techniques	Monte Carlo simulation model
Significant unobservable inputs	Volatility of Canopy Growth share price
Relationship of unobservable inputs to fair value	Increase or decrease in volatility will result in an increase or decrease in fair value
BioSteel Redeemable Noncontrolling Interest Discount Rate
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Valuation techniques	Discounted cash flow
Significant unobservable inputs	Discount rate
Relationship of unobservable inputs to fair value	Increase or decrease in discount rate will result in a decrease or increase in fair value
BioSteel Redeemable Noncontrolling Interest Future Wholesale Price and Production Levels
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Significant unobservable inputs	Future wholesale price and production levels
Relationship of unobservable inputs to fair value	Increase or decrease in future wholesale price and production levels will result in an increase or decrease in fair value
Vert Mirabel Redeemable Noncontrolling Interest Future Wholesale Price and Production Levels Discount Rate
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Valuation techniques	Discounted cash flow
Significant unobservable inputs	Discount rate
Relationship of unobservable inputs to fair value	Increase or decrease in discount rate will result in a decrease or increase in fair value
Vert Mirabel Redeemable Noncontrolling Interest Future Wholesale Price and Production Levels
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Significant unobservable inputs	Future wholesale price and production levels
Relationship of unobservable inputs to fair value	Increase or decrease in future wholesale price and production levels will result in an increase or decrease in fair value

Fair Value of Financial Instr_6

Fair Value of Financial Instruments - Additional Information (Details) - CAD ($)	Jun. 30, 2021	Jun. 30, 2020
Fair Value Disclosures [Abstract]
Fair value, transfers of amounts between levels	$ 0	$ 0

Revenue - Summary of Disaggrega

Revenue - Summary of Disaggregation of Revenue (Details) - CAD ($) $ in Thousands		3 Months Ended
		Jun. 30, 2021	Jun. 30, 2020
Disaggregation Of Revenue [Line Items]
Gross revenue		$ 155,423	$ 119,088
Net revenue		136,209	110,416
Canadian Recreational Cannabis Net Revenue
Disaggregation Of Revenue [Line Items]
Gross revenue		60,037	44,264
Canadian Medical Cannabis Net Revenue
Disaggregation Of Revenue [Line Items]
Gross revenue	[1]	13,492	13,910
Canadian Cannabis Net Revenue
Disaggregation Of Revenue [Line Items]
Gross revenue		73,529	58,174
International and Other Revenue
Disaggregation Of Revenue [Line Items]
Gross revenue		19,410	21,108
Global Cannabis Net Revenue
Disaggregation Of Revenue [Line Items]
Gross revenue		92,939	79,282
Consumer Products and Other
Disaggregation Of Revenue [Line Items]
Gross revenue		43,270	31,134
C3 | International and Other Revenue
Disaggregation Of Revenue [Line Items]
Gross revenue		11,443	15,369
Business to Business | Canadian Recreational Cannabis Net Revenue
Disaggregation Of Revenue [Line Items]
Gross revenue	[2]	42,693	34,934
Business to Consumer | Canadian Recreational Cannabis Net Revenue
Disaggregation Of Revenue [Line Items]
Gross revenue		17,344	9,330
Other | International and Other Revenue
Disaggregation Of Revenue [Line Items]
Gross revenue		7,967	5,739
Other | Consumer Products and Other
Disaggregation Of Revenue [Line Items]
Gross revenue		5,988	5,517
Storz & Bickel | Consumer Products and Other
Disaggregation Of Revenue [Line Items]
Gross revenue		24,070	17,120
This Work | Consumer Products and Other
Disaggregation Of Revenue [Line Items]
Gross revenue		6,551	6,049
Bio Steel | Consumer Products and Other
Disaggregation Of Revenue [Line Items]
Gross revenue		$ 6,661	$ 2,448
[1]	Canadian medical cannabis net revenue reflects excise taxes of $1,380 (three months ended June 30, 2020 – $1,426).
[2]	Canadian recreational business-to-business net revenue reflects excise taxes of $17,834 (three months ended June 30, 2020

Revenue - Summary of Disaggre_2

Revenue - Summary of Disaggregation of Revenue (Parenthetical) (Details) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Disaggregation Of Revenue [Line Items]
Net revenue	$ 136,209	$ 110,416
CANADA
Disaggregation Of Revenue [Line Items]
Net revenue	82,612	65,717
CANADA | Recreational Cannabis Revenue
Disaggregation Of Revenue [Line Items]
Net revenue	17,834	7,246
CANADA | Medical Cannabis Revenue
Disaggregation Of Revenue [Line Items]
Net revenue	$ 1,380	$ 1,426

Revenue - Additional Informatio

Revenue - Additional Information (Details) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Mar. 31, 2021
Revenue From Contract With Customer [Abstract]
Allowance for estimated returns and price adjustments	$ 3,000	$ 3,400
Liability for estimated returns and price adjustments	$ 8,387		$ 6,441

Other Income (Expense), Net - S

Other Income (Expense), Net - Schedule of Other Income (Expense), Net (Details) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Other Income And Expenses [Abstract]
Fair value changes on other financial assets	$ 84,152	$ 21,807
Fair value changes on liability arising from Acreage Arrangement	150,000	(35,000)
Fair value changes on convertible senior notes	50,712	(20,334)
Fair value change on warrant derivative liability	316,257	35,369
Fair value changes on acquisition related contingent consideration	(199)	39,983
Interest income	2,647	8,993
Interest expense	(24,564)	(1,155)
Foreign currency loss	1,030	(5,959)
Loss on disposal of consolidated entity	(2,339)
Other income (expense), net	2,970	4,501
Other income (expense), net	$ 580,666	$ 48,205

Acquisitions - Summary of Conso

Acquisitions - Summary of Consolidated Balance Sheet Impact at Acquisition of Company's Business Combinations (Details) - CAD ($) $ in Thousands	Jun. 22, 2021	Apr. 01, 2021	Jun. 30, 2021	Mar. 31, 2021	Mar. 31, 2020
Business Acquisition [Line Items]
Goodwill			$ 2,000,458	$ 1,889,354	$ 1,954,471
Ace Valley
Business Acquisition [Line Items]
Cash and cash equivalents			1,544
Inventory			878
Other current assets			2,249
Property, plant and equipment			105
Goodwill			36,464
Accounts payable and other accrued expenses and liabilities			(1,148)
Net assets acquired			54,092
Consideration paid in cash			51,623
Other consideration			2,469
Total consideration		$ 51,623	54,092
Less: Cash and cash equivalents acquired			(1,544)
Net cash outflow (inflow)			50,079
Ace Valley | Brands
Business Acquisition [Line Items]
Intangible assets			14,000
Supreme Cannabis [Member]
Business Acquisition [Line Items]
Cash and cash equivalents			41,306
Inventory			33,681
Other current assets			15,145
Property, plant and equipment			179,123
Goodwill			85,910
Accounts payable and other accrued expenses and liabilities			(13,258)
Debt and other liabilities			(90,482)
Deferred income tax liabilities			(6,157)
Net assets acquired			279,668
Consideration paid in cash	$ 84		$ 84
Consideration paid in shares			260,668
Replacement options	$ 140,159		$ 629
Replacement warrants			13,350
Other consideration			4,937
Total consideration			279,668
Less: Cash and cash equivalents acquired			(41,306)
Net cash outflow (inflow)			(41,222)
Supreme Cannabis [Member] | Brands
Business Acquisition [Line Items]
Intangible assets			20,900
Supreme Cannabis [Member] | Distribution Channel
Business Acquisition [Line Items]
Intangible assets			3,000
Supreme Cannabis [Member] | Operating Licenses
Business Acquisition [Line Items]
Intangible assets			10,500
Two Thousand And Twenty Acquisitions
Business Acquisition [Line Items]
Cash and cash equivalents			42,850
Inventory			34,559
Other current assets			17,394
Property, plant and equipment			179,228
Goodwill			122,374
Accounts payable and other accrued expenses and liabilities			(14,406)
Debt and other liabilities			(90,482)
Deferred income tax liabilities			(6,157)
Net assets acquired			333,760
Consideration paid in cash			$ 51,707
Consideration paid in shares			260,668
Replacement options			$ 629
Replacement warrants			13,350
Other consideration			7,406
Total consideration			333,760
Less: Cash and cash equivalents acquired			(42,850)
Net cash outflow (inflow)			8,857
Two Thousand And Twenty Acquisitions | Brands
Business Acquisition [Line Items]
Intangible assets			34,900
Two Thousand And Twenty Acquisitions | Distribution Channel
Business Acquisition [Line Items]
Intangible assets			3,000
Two Thousand And Twenty Acquisitions | Operating Licenses
Business Acquisition [Line Items]
Intangible assets			$ 10,500

Acquisitions - Additional Infor

Acquisitions - Additional Information (Details)	Jun. 30, 2021CAD ($)
C3
Business Acquisition [Line Items]
Goodwill expected to be deductible for income tax purposes	$ 0

Acquisitions - Ace Valley - Add

Acquisitions - Ace Valley - Additional Information (Details) - Ace Valley - CAD ($) $ in Thousands	Apr. 01, 2021	Jun. 30, 2021
Business Acquisition [Line Items]
Business acquisition, acquisition date	Apr. 1, 2021
Percentage of outstanding shares purchased	100.00%
Business acquisition, total purchase consideration	$ 51,623	$ 54,092
Business Combination, Contingent Consideration, Liability	$ 2,469

Acquisitions - Supreme Cannabis

Acquisitions - Supreme Cannabis - Additional Information (Details) $ in Thousands	Jun. 22, 2021CAD ($)Instrumentshares	Jun. 30, 2021CAD ($)shares	Jun. 30, 2020shares
Business Acquisition [Line Items]
Number of shares | shares		9,888,801	1,164,339
Supreme Cannabis [Member]
Business Acquisition [Line Items]
Name of acquiree		Supreme Cannabis
Date of acquisition	Jun. 22, 2021
Percentage of outstanding shares purchased	100.00%
Number of shares | shares	9,013,400
Shares issued, value	$ 260,668
Consideration paid in cash	84	$ 84
Replacement options	140,159	$ 629
Fair value of outstanding warrant	13,350
Fair value of replacement options	1,452
Fair value of replacement options included as consideration paid	629
Fair value of replacement options recognized as share-based compensation expense	823
Supreme Cannabis [Member] | Debentures Subject to Mandatory Redemption
Business Acquisition [Line Items]
Principal amount of convertible debt	$ 26,968
Number of shares convertible | Instrument	94,625,183
Share exchange ratio	0.011659
Fair value of debt	$ 36,751
Conversion feature of debt	4,937
Debt component	$ 31,814
Supreme Cannabis [Member] | Warrant
Business Acquisition [Line Items]
Number of shares | shares	1,265,742

Acreage Arrangement and Amend_2

Acreage Arrangement and Amendments to Cbi Investor Rights Agreement and Warrants - Additional Information (Details) $ / shares in Units, $ in Thousands	Sep. 23, 2020CAD ($)$ / shares	Sep. 23, 2020USD ($)	Jun. 30, 2021CAD ($)shares	Jun. 30, 2021USD ($)	Jun. 30, 2020CAD ($)	Mar. 31, 2021CAD ($)	Sep. 23, 2020USD ($)	Jun. 24, 2020shares	Apr. 18, 2019$ / sharesshares
Business Acquisition [Line Items]
Debentures bear interest rate per annum			6.10%
Warrant expiration date									Nov. 1, 2023
Estimated fair value			$ (316,257,000)		$ (35,369,000)
Tranche A Warrants
Business Acquisition [Line Items]
Warrants to acquire shares | shares									88,500,000
Exercise price of warrants | $ / shares									$ 50.40
Tranche B Warrants
Business Acquisition [Line Items]
Warrants to acquire shares | shares									38,500,000
Exercise price of warrants | $ / shares									$ 76.68
Tranche C Warrants
Business Acquisition [Line Items]
Warrants to acquire shares | shares									12,800,000
Tranche B and C Warrants | Second Amended and Restated Investor Rights Agreement and Consent Agreement
Business Acquisition [Line Items]
Number of common stock shares to be repurchased to avoid providing repurchase credit | shares			27,378,866
Value of common stock to be repurchased to avoid providing repurchase credit			$ 1,583,000,000
Derivative liability			0
Debenture
Business Acquisition [Line Items]
Gain (Loss) on derivative, Net			943,000
Payments to acquire investments			66,995,000	$ 50,000
Fair value of debt	$ 28,391,000						$ 27,448
Additional payment upon satisfaction of certain conditions				$ 50,000
Warrant
Business Acquisition [Line Items]
Derivative, financial liability			299,318,000			$ 615,575,000
Estimated fair value			316,257,000		35,369,000
Maximum [Member] | Second Amended and Restated Investor Rights Agreement and Consent Agreement
Business Acquisition [Line Items]
Share repurchase credit limit			1,583,000,000
Acreage
Business Acquisition [Line Items]
Aggregate payment	$ 49,849,000	$ 37,500
Gain (Loss) on derivative, Net			150,000,000		$ 35,000,000
Acreage | Acreage Financial Instrument
Business Acquisition [Line Items]
Derivative, financial liability			$ 450,000,000			$ 600,000,000
Acreage | Maximum [Member]
Business Acquisition [Line Items]
Number Of Fixed And Floating Shares Issued | shares								32,700,000
Acreage | Class E Subordinated Voting Shares | Fixed Shares
Business Acquisition [Line Items]
Common stock shares conversion ratio	0.3048	0.3048
Acreage | Class D Subordinated Voting Shares | Floating Shares
Business Acquisition [Line Items]
Minimum call price | $ / shares	$ 6.41

Segment Information - Additiona

Segment Information - Additional Information (Details)	3 Months Ended
	Jun. 30, 2021SegmentCustomer	Jun. 30, 2020Customer
Segment Reporting Information [Line Items]
Number of operating segments | Segment	2
Customer Concentration Risk | Revenue from Contract with Customer Benchmark
Segment Reporting Information [Line Items]
Concentration Risk Customer Number Of Customers | Customer	1	1

Segment Information - Summary o

Segment Information - Summary of Reconciliation of Operating Profit (Loss) from Segments to Consolidated (Details) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Segment Reporting Information [Line Items]
Net revenue	$ 136,209	$ 110,416
Gross margin	27,238	6,495
Selling, general and administrative expenses	112,574	135,392
Share-based compensation	13,126	30,685
Asset impairment and restructuring costs	89,249	12,794
Operating loss	(187,711)	(172,376)
Loss from equity method investments	(100)	(7,189)
Other income (expense), net	580,666	48,205
Income (loss) before income taxes	392,855	(131,360)
Global Cannabis
Segment Reporting Information [Line Items]
Net revenue	92,939	79,282
Gross margin	13,369	(6,858)
Other Consumer Products
Segment Reporting Information [Line Items]
Net revenue	43,270	31,134
Gross margin	$ 13,869	$ 13,353

Segment Information - Summary_2

Segment Information - Summary of Disaggregation of Net Revenue by Geographic Area (Details) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Revenues From External Customers And Long Lived Assets [Line Items]
Net revenue	$ 136,209	$ 110,416
CANADA
Revenues From External Customers And Long Lived Assets [Line Items]
Net revenue	82,612	65,717
Germany
Revenues From External Customers And Long Lived Assets [Line Items]
Net revenue	26,106	27,997
United States
Revenues From External Customers And Long Lived Assets [Line Items]
Net revenue	19,867	10,445
Other
Revenues From External Customers And Long Lived Assets [Line Items]
Net revenue	$ 7,624	$ 6,257

Segment Information - Summary_3

Segment Information - Summary of Disaggregation of Long-lived Tangible Assets by Geographic Areas (Details) - CAD ($) $ in Thousands	Jun. 30, 2021	Mar. 31, 2021
Revenues From External Customers And Long Lived Assets [Line Items]
Net revenue	$ 1,142,614	$ 1,074,537
CANADA
Revenues From External Customers And Long Lived Assets [Line Items]
Net revenue	931,042	847,678
United States
Revenues From External Customers And Long Lived Assets [Line Items]
Net revenue	143,283	143,747
Other
Revenues From External Customers And Long Lived Assets [Line Items]
Net revenue	$ 68,289	$ 83,112